REVIEW ARTICLE
published: 23 April 2012
doi: 10.3389/fmicb.2012.00130

Secondary metabolites from plants inhibiting ABC
transporters and reversing resistance of cancer cells and
microbes to cytotoxic and antimicrobial agents

Michael Wink 1*, Mohamed L. Ashour 2 and Mahmoud Zaki El-Readi 1,3

1 Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
2 Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
3 Department of Biochemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt

Edited by:
Bruce C. Campbell, Western Regional
Research Centre, USA
Reviewed by:
Jon Y. Takemoto, Utah State
University, USA
Dominique Sanglard, University of
Lausanne and University Hospital
Center, Switzerland
Slawomir Milewski, Gdansk
University of Technology, Poland
*Correspondence:
Michael Wink, Institute of Pharmacy
and Molecular Biotechnology,
Heidelberg University, INF 263,
D-69221 Heidelberg, Germany.
e-mail: wink@uni-hd.de

Fungal, bacterial, and cancer cells can develop resistance against antifungal, antibacterial, or
anticancer agents. Mechanisms of resistance are complex and often multifactorial. Mech-
anisms include: (1) Activation of ATP-binding cassette (ABC) transporters, such as P-gp,
which pump out lipophilic compounds that have entered a cell, (2) Activation of cytochrome
p450 oxidases which can oxidize lipophilic agents to make them more hydrophilic and
accessible for conjugation reaction with glucuronic acid, sulfate, or amino acids, and (3)
Activation of glutathione transferase, which can conjugate xenobiotics.This review summa-
rizes the evidence that secondary metabolites (SM) of plants, such as alkaloids, phenolics,
and terpenoids can interfere with ABC transporters in cancer cells, parasites, bacteria,
and fungi. Among the active natural products several lipophilic terpenoids [monoterpenes,
diterpenes, triterpenes (including saponins), steroids (including cardiac glycosides), and
tetraterpenes] but also some alkaloids (isoquinoline, protoberberine, quinoline, indole,
monoterpene indole, and steroidal alkaloids) function probably as competitive inhibitors
of P-gp, multiple resistance-associated protein 1, and Breast cancer resistance protein
in cancer cells, or efﬂux pumps in bacteria (NorA) and fungi. More polar phenolics (phe-
nolic acids, ﬂavonoids, catechins, chalcones, xanthones, stilbenes, anthocyanins, tannins,
anthraquinones, and naphthoquinones) directly inhibit proteins forming several hydrogen
and ionic bonds and thus disturbing the 3D structure of the transporters. The natural prod-
ucts may be interesting in medicine or agriculture as they can enhance the activity of active
chemotherapeutics or pesticides or even reverse multidrug resistance, at least partially, of
adapted and resistant cells. If these SM are applied in combination with a cytotoxic or
antimicrobial agent, they may reverse resistance in a synergistic fashion.

Keywords: ABC transporter, P-gp, MDR, MRP1, secondary metabolites, review

INTRODUCTION
EVOLUTIONARY AND ECOLOGICAL BACKGROUND
Plants are sessile organisms which cannot run away when attacked
by an herbivore nor do they have an immune system to combat
infesting parasites, bacteria, fungi, or viruses. From early days of
the evolution of land plants they had to cope with these envi-
ronmental challenges. Plants developed a number of mechanical
traits, such as resistant epidermal and bark tissues but also spines
and thorns as defense tools. In addition, plants evolved a high
diversity of defense chemicals, the so-called secondary metabo-
lites (SM; Table 1). Besides defense, some SM function as signal
compounds or protect against oxidative or UV stress (Wink, 1988,
2003, 2008b, 2010a,b).

The structures of SM have been optimized during evolution
in such a way that they can interfere with molecular targets

Abbreviations: ABC, ATP-binding cassette; BCRP, breast cancer resistance protein;
MDR, multidrug resistance; MRP1, multidrug resistance-associate protein; P-gp,
P-glycoprotein.

in herbivores and microbes. The main group of targets include
(1) proteins, (2) DNA, RNA, and (3) the biomembrane (Wink,
2008a,b; Wink and Schimmer, 2010). Neuronal signal transduc-
tion is a central and speciﬁc target in animals and many SM,
especially alkaloids and amines are directed toward it (Wink,
1993, 2000). SM which interfere with proteins, such as polyphe-
nols, biomembranes (saponins and other lipophilic terpenoids), or
DNA (alkylating or intercalating mutagens) affect a wider range
of organisms, including animals and microbes. In general, mem-
brane and DNA active SM have cytotoxic properties. Affected cells
usually undergo apoptosis (Wink, 2007). Several SM interfere with
the neuronal signal transduction in animals and are thus potent
neurotoxins (Wink, 1993, 2000).

A large number of SM have lipophilic properties which enable
them to readily pass biomembranes in target organisms by simple
diffusion. These SM are also dangerous for the producing plants.
Therefore, they are usually stored in dead tissue away from living
cells, such as resin ducts, oil cells, trichomes, or cuticles (Wink,
2010b). The absorption of polar SM is usually slower or does not

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 1

Wink et al.

Inhibition of ABC transporter

Table 1 | Structural types of secondary metabolites and known
structures.

Class

Number of structures

WITH NITROGEN
Alkaloids
Non-protein amino acids (NPAA)
Amines
Cyanogenic glucosides
Glucosinolates
Alkamides
Lectins, peptides
WITHOUT NITROGEN
Monoterpenes (incl. iridoids)
Sesquiterpenes
Diterpenes
Triterpenes, steroids, saponins
Tetraterpenes
Phenylpropanoids, phenolic acids,
coumarins, lignans
Flavonoids, isoﬂavonoids, anthocyanins,
stilbenoids, tannins, xanthones
Polyacetylenes, fatty acids, waxes
Polyketides (quinones, anthraquinones)
Carbohydrates, organic acids

21000
700
100
60
100
150
2000

2500
5000
2500
5000
500
2000

10000

1500
750
400

take place at all, with the exception of SM that can use transporters
for sugars or amino acids or endocytosis as a kind of “stowaway.”
Furthermore, SM usually occur in complex mixtures which may
contain SM (such as saponins) that can facilitate the uptake of
polar SM (Hebestreit and Melzig, 2003).

THE RESPONSE OF HERBIVORES AND PATHOGENS AGAINST PLANT
DEFENSE CHEMICALS
In the evolutionary arms race herbivores and microbes evolved
mechanisms to avoid or inactivate the defense chemistry of plants.
Mechanisms of resistance in animals and humans are complex and
often multifactorial. Mechanisms include: (1) Activation of ATP-
binding cassette (ABC) transporters, such as p-gp, which pump
out lipophilic compounds that have entered a cell, (2) activation
of cytochrome p450 oxidases (CYP) which can oxidize lipophilic
agents to make them more hydrophilic and accessible for conju-
gation reaction with glucuronic acid, sulfate, or amino acids, and
(3) activation of glutathione transferase (GST), which can conju-
gate xenobiotics with glutathione. The reactions of CYP, GST, and
conjugation are well known in pharmacology and categorized as
phase I and phase II reactions. These reactions are important in
the metabolism of medicinal drugs and toxins. This evolutionary
history also applies for humans which enables us to metabolize a
large number of xenobiotics.

In phase I, a lipophilic SM is made more hydrophilic by intro-
ducing hydroxyl groups. This reaction is catalyzed by CYP and
CYP1A1, CYP1A2, CYP3A4, and CYP2D6 are the most important
enzymes. Furthermore, these CYP can cleave N -methyl, O-methyl,
or methylene groups in order to obtain a more hydrophilic or bet-
ter accessible substrate (Guengerich, 2001). In the human genome,

about 57 active CYP genes are known (Ingelman-Sundberg and
Gomez, 2010). A substantial polymorphism of CYPs exists which
enables them to metabolize a wide range of xenobiotics. The regu-
lation of the corresponding genes is only partly known. The genes
encoding these enzymes, which occur in intestinal epithelia and
in the liver, are inducible by SM that have entered the body. In
phase II, the hydroxylated xenobiotics are conjugated with polar
molecules, such as glutathione, sulfate, or glucuronic acid. These
conjugates are eliminated via the kidneys and urine. That means,
on exposure to lipophilic SM, genes which encode these enzymes
are often induced and that activation can inactivate the toxins.
Several SM carry methylenedioxy groups on their phenolic rings,
such as in the isoquinoline alkaloids berberine and hydrastine,
which are assumed to be inhibitors of CYP (Wink, 2007). Alka-
loids which can inhibit CYP have been summarized by Wink
(2007).

Resistance mechanisms in bacterial pathogens are even more
evident because several pathogens already have evolved resis-
tance against medicinally used antibiotics. The main mechanisms
include:
• Direct inactivation of the antibiotic, e.g., by cleavage of the
beta-lactam ring of penicillin by beta-lactams or acetylation,
methylation of other antibiotics
• Target site modiﬁcation: molecular change of the target mole-
cule (proteins, rRNA) in such a way that the antibiotic cannot
bind any longer
• Bypass or alteration of metabolic pathways in cases where an
antibiotic blocks a pathway (e.g., as for sulfonamides)
• Prevention of drug uptake
• Export out of the cell by ABC transporters so that the intra-
cellular concentration of an antibiotic (e.g., tetracycline) are
reduced. In Bacteria, this is one of several factors responsible
for multidrug resistance (MDR).

ABC TRANSPORTER
Resistance against defense chemicals can be obtained through the
expression of ABC transporters that are present in most cells and
organisms. They are especially active in epithelia of intestinal, liver,
kidney, and endothelia (Twentyman and Bleehen, 1991; Nielsen
and Skovsgaard, 1992; Nooter and Stoter, 1996; Steinbach et al.,
2002; You and Morris, 2007).

Three types of ABC transporters have been studied in detail:

1. P-glycoprotein (P-gp; molecular weight 170 kD) or MDR1 pro-
tein (multiple drug resistance protein) was the ﬁrst cloned ABC
transporter. It is encoded by the ABCB1 gene. P-gp is composed
of two similar moieties and each half contains one transmem-
brane and one ATP-binding domain. P-gp is an efﬂux pump
directed to the gut lumen. The substrate molecules bind to
transmembrane domains and then are exported to extracellu-
lar space, driven by the energy of ATP hydrolysis. A wide range
of lipophilic chemotherapeutical agents, such as anthracenes,
anthracyclines, epipodophyllotoxins, taxanes, and Vinca alka-
loids, which can enter tumor cells by free diffusion, are sub-
strates of P-gp and can be extruded by the transporter (Loo
and Clarke, 2005).

Frontiers in Microbiology | Fungi and Their Interactions

April 2012 | Volume 3 | Article 130 | 2

Wink et al.

Inhibition of ABC transporter

2. Multiple resistance-associated protein 1 (MRP1; 190 kD) is
encoded by the ABCC1 gene. MRP1 transports drugs conju-
gated to glutathione (GSH), and also unmodiﬁed therapeutics
in the presence of GSH (van der Kolk et al., 1999). MRP1
is structurally similar to P-gp, and can expel anthracene-
dione, anthracycline, epipodophyllotoxin, Vinca alkaloids, etc.
(Wijnholds et al., 2000).

3. Breast cancer resistance protein (BCRP; 72 kD) is the prod-
uct of the ABCG2 gene. It has one transmembrane domain
and one ATP-binding domain and only functions after dimer-
ization. BCRP confers resistance to doxorubicin, camptothecin,
and mitoxantrone (Ambudkar et al., 1999; Schinkel and Jonker,
2003; Mao and Unadkat, 2005; Krishnamurthy and Schuetz,
2006).

Breast cancer resistance protein and P-gp are highly expressed at
the apical membrane of blood–brain barrier (BBB), placenta, liver,
intestine, and other organs (Schinkel and Jonker, 2003). These
ATP-driven transporters can pump lipophilic compounds out of
the cell, either back to the gut lumen or into the blood system,
thus reducing the intracellular concentration of potentially toxic
compounds.

ATP-binding cassette transporters are also important at the
BBB. The BBB only allows the entry of small lipophilic sub-
stances by passive diffusion. However, the uptake of lipophilic
compounds in the brain is relatively low due to the high activ-
ity of P-gp, MRP, and organic anion transporting polypeptides
(OATPs). These transporters catalyze a rapid efﬂux of lipophilic
xenobiotics from the CNS (Elsinga et al., 2004; Mahringer and
Fricker, 2010).

Multidrug resistance was discovered during chemotherapy of
cancer patients who developed resistance against a cytotoxic drug.
It transpired that the tumor cells were able to pump out the
lipophilic alkaloids (such as Vinca alkaloids, taxanes, and anthracy-
cline derivatives) at almost the same speed as they were entering the
tumor cells. Activated cells became resistant to vincristine but also
to several other lipophilic drugs. This means that a cross-resistance
or MDR had occurred. As a consequence, a major obstacle to the
successful chemotherapy of tumors is MDR. Upon exposure to
xenobiotics MDR genes can become upregulated. Overexpressed
ABC transporters (P-gp, MRP1, or BCRP) can mediate resistance
of tumor cells against a variety of anticancer drugs (Schinkel and
Jonker, 2003). This phenomenon is called MDR, which is one of
the most important reasons of chemotherapy failure (Gottesman,
2002).

Several of human protozoal parasites (Plasmodium, Leishma-
nia, Trypanosoma) can develop resistance against prophylactic
and therapeutic agents, such as quinolines, naphthoquinones,
sesquiterpene lactones, and others. The underlying mechanism
includes membrane glycoproteins that are orthologous to human
P-gp. These ABC transporters can also be induced and activated.
ATP-binding cassette transporters are also present in bacteria
and fungi in which they confer resistance to antibiotics and fungi-
cidal compounds (Steffens et al., 1996). A medicinally important
issue is the increasing resistance of bacteria toward antibiotics,
and ABC transporters can be involved in bacterial MDR (besides
other mechanisms discussed above). Apparently,ABC transporters

are an old invention of nature, which occur from E. coli to
Homo sapiens.

OVERCOMING RESISTANCE CAUSED BY ABC
TRANSPORTERS
Multidrug resistance reversal agents are also called chemosen-
sitizers or modulators. They can inhibit the efﬂux activity of
transporters and other relevant MDR targets (see above); in conse-
quence they can potentiate cytotoxicity, and are therefore impor-
tant alternatives to overcome MDR (Watanabe et al., 1995; Dantzig
et al., 1996; Robert and Jarry, 2003).

Multi-resistant tumor cells frequently express different ABC
transporters simultaneously, e.g., P-gp, MRP1, BCRP, and others
(Annereau et al., 2004; Gillet et al., 2004). Because the substrate
spectra of ABC transporters only partly overlap, co-expression
of transporters might produce more diverse resistance proﬁles
than those of any one member alone. Thus broad-spectrum rever-
sal agents are needed and some compounds exhibit this prop-
erty (Hyaﬁl et al., 1993; Maliepaard et al., 2001; Brooks et al.,
2003).

A number of natural or synthetic compounds have been dis-
covered that can inhibit P-gp and re-sensitize resistant tumor
cells in vitro (Chauffert et al., 1990; Genne et al., 1992; He and
Liu, 2002; Wink, 2007). Although these agents work successfully
in some patients, most results of clinical trials were disappoint-
ing (Solary et al., 2000; Dantzig et al., 2001). Some of these
reversal agents did not work in vivo or some had too severe
side effects. Therefore, new and better reversal agents are still
needed.

Most modulators of ABC transporters act by binding to mem-
brane transport proteins (especially P-gp, MRP1, and BCRP) as
competitive inhibitors, or by indirect mechanisms related to phos-
phorylation of the transport proteins, or the expression of the
mdr1 and mrp1 genes. Other inhibitors not only act at the level
of the transporter gene but inﬂuence their expression; for exam-
ple, the alkaloid piperine lowered the expression levels of ABCB1,
ABCC1, and ABCG2 genes which encode P-gp, MRP1, and BCRP
(Li et al., 2011b).

INHIBITORS OF ABC TRANSPORTERS FROM PLANTS
For this review we carried out a comprehensive literature research.
Table 2 summarizes the search results for SM from plants, which
can serve as ABC transporter substrates and might be useful
in strategies to reverse drug resistance in cancer cells, fungi,
and parasites. Compounds affecting other resistance mechanisms,
which are important and which were discussed above, were not
considered in this review.

Lipophilic SM, such as monoterpenes, diterpenes, triterpenes
(including saponins), steroids (including cardiac glycosides), and
tetraterpenes (carotenoids; Table 2) function as substrates for P-gp
in cancer cells. The ABC transporter from fungi, AtrB (Andrade
et al., 2000), or the NorA efﬂux pump in Staphylococcus aureus can
also be affected (Smith et al., 2007). Because of their lipophilicity,
these terpenoids most likely are substrates for P-gp and other ABC
transporter. If administered as a chemosensitizer in combination
with a cytotoxic agent they function as inhibitors competing for
binding to the active side of the transporters.

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 3

Wink et al.

Inhibition of ABC transporter

Table 2 | Secondary metabolites from plants that can inhibit P-gp, MRP1, BCRP, bacterial, and fungal ABC transporters.

Natural product

Occurrence

Activities

Reference

TERPENOIDS
Monoterpenes
Citronellal, citronellol

Diterpenes
Andrographolide

Jatrophane diterpene
polyesters

Latilagascene A, latilagascene
B, latilagascene C (lathyrane
diterpenes)
Totarol

Triterpenes
Aegicerin

Betulinic acid, pomolic acid

Limonin, deacetylnomilin

Dyscusin A, cumingianol A–F,
cumingianoside R
Euscaphic acid, tormentic
acid, 2 α -acetyl tormentic
acid, 3β-acetyl tormentic acid
Glycyrrhizin
21α-Hydroxytaraxasterol and
related triterpenes
Obacunone,
12-alpha-hydroxylimonin
Phytolacca saponins N-1–N-5

Sinocalycanchinensin E

β-Amyrin, uvaol, oleanolic acid

Steroids
Cardenolides
Cycloartanes
(9,19-cyclopropyl-triterpenes)
Digoxin, digitoxin

Ginsenoside Rc, ginsenosides
Rd, parishin C
Methylprototribestin

Protopanaxatriol (ginsenoside)

Zanthoxylum piperitum
(Rutaceae)

1

Yoshida et al. (2005)

Andrographis paniculata
(Acanthaceae)
Euphorbia serrulata, E. esula, E.
salicifolia, E. peplus
(Euphorbiaceae)
Euphorbia lagascae
(Euphorbiaceae)

2 (biphasic action)

Najar et al. (2010)

3 in mouse lymphoma cells

Hohmann et al. (2002)

4, 5

Duarte et al. (2006)

Podocarpus totara
(Podocarpaceae)

Inhibits Staphylococcus aureus
NorA efﬂux pump

Smith et al. (2007)

Clavija procera
(Theophrastaceae)
Licania tomentosa,
Chrysobalanus icaco,
(Chrysobalanaceae)
Citrus jambhiri, Citrus pyriformis,
Phellodendron amurense
(Rutaceae)
Dysoxylum cumingianum
(Meliaceae)
Cecropia lyratiloba (Moraceae)

Glycyrrhiza glabra (Fabaceae)
Euphorbia lagascae
(Euphorbiaceae)
Phellodendron amurense
(Rutaceae)
Phytolacca americana
(Phytolaccaceae)
Sinocalycanthus chinensis
(Calycanthaceae)
Carpobrotus edulis (Aizoaceae)

Nerium oleander (Apocynaceae)
Euphorbia species
(Euphorbiaceae)
Digitalis spp. (Plantaginaceae)

Reverses MDR in resistant
Mycobacterium tuberculosis strains
3 in leukemia cells

Rojas et al. (2006)

Fernandes et al. (2003)

6

Min et al. (2007), El-Readi et al. (2010)

3 in cancer cells; 7

Kurimoto et al. (2011a,b)

3 in leukemia cell line

Rocha Gda et al. (2007)

2 (biphasic action)
6, 7

Najar et al. (2010)
Duarte et al. (2009)

1 in MDR cancer cells

Min et al. (2007)

3 in 2780 AD cells

Wang et al. (2008)

Enhances colchicine-induced
cytotoxicity in MDR KB cells
3 in mouse lymphoma cell line and
Gram-positive bacteria

Kashiwada et al. (2011)

Martins et al. (2010), Ordway et al.
(2003)

3 ovarian cancer 2780AD cells
8

Zhao et al. (2007)
Madureira et al. (2004)

Panax spp. (Araliaceae)

4 in lymphoma cells

2

de Lannoy and Silverman (1992),
Cavet et al. (1996)
Berek et al. (2001)

Tribulus terrestris
(Zygophyllaceae)
Panax ginseng (Araliaceae)

4 (doxorubicin)

Ivanova et al. (2009)

2, 4 in AML-2/D100 cells

Choi et al. (2003)

(Continued)

Frontiers in Microbiology | Fungi and Their Interactions

April 2012 | Volume 3 | Article 130 | 4

Wink et al.

Table 2 | Continued

Inhibition of ABC transporter

Natural product

Occurrence

Activities

Reference

1 in Caco2 and leukemia cells

El-Readi et al. (2010)

4 in K562/Adr cells

Suttana et al. (2010)

Stigmasterol,
β-sitosterol-O-glucoside
Withaferin A
Tetraterpenes
Carotenoids (lycopene,
violaxanthin, and related
compounds)
PHENOLICS
Phenyl propanoids
Chlorogenic acid

Citrus jambhiri, Citrus pyriformis
(Rutaceae)
Withania somnifera (Solanaceae)

Capsicum annuum (Solanaceae);
Daucus carota spp. sativus
(Apiaceae)

Coffea arabica (Rubiaceae) and
many plants
Curcuma longa (Zingiberaceae)

1, 9

1

Curcumin,
tetrahydrocurcumin
Flavonoids, catechins, chalcones, xanthones, stilbenes, anthocyanins, and related polyphenols
Acacetin

Several families

1, 5

Afrormosin, robinin,
amorphigenin
Ampelopsin
Apigenin,

Baicalein

Biochanin A
Calodenin B, dihydrocalodenin
B, and other dimeric
proanthocyanidins
Chrysin

Several Fabaceae

Hovenia dulcis (Rhamnaceae)
Several plants

Scutellaria baicalensis
(Lamiaceae)

Several families
Ochna macrocalyx (Ochnaceae)

Several species

1, 10 in human erythrocytes and
breast cancer cells
1, 10

1, 5 in K562/ADR cells
1, 4, 9, 10 in MES-SA/DX5 cells;
substrate for multidrug transporter
in Plasmodium falciparum
Substrate for Yorlp and Pdr5p
transporters in yeast
Saccharomyces cerevisiae
1, 9
Inhibit MDR in Staphylococcus
aureus (RN4220, XU212, and
SA-1199-B)
1, 2 (biphasic action), 9

Chrysosplenol-D,
chrysoplenetin
Cyanidin, callistephin,
pelargonin, ideanin, cyanin,
pelargonidin, and related
anthocyanidins
Daidzein

Artemisia annua L. (Asteraceae)

Glycine max L. Merr. (Fabaceae),
Aronia melanocarpa L.
(Rosaceae)

Synergistic inhibition of MDR in
Staphylococcus aureus
1

Several species of Fabaceae

1, 9, 10

5,7-Dimethoxyﬂavone,
kaempferide
Diosmin
Ellagic acid, tannic acid

Kaempferia parviﬂora
(Zingiberaceae)
Citrus spp. (Rutaceae)
Several species

Epicatechin, epicatechin
gallate, epigallocatechin,
epigallocatechin gallate
(EGCG)

Camellia sinensis (Theaceae);
Carpobrotus edulis (Aizoaceae)

9 (in vitro and in vivo)

2
Inhibit an efﬂux pump in
Acinetobacter baumannii and
enhances antibiotic activity
1 in MCF-7/Adr and mouse
lymphoma cell line; 9, 10; 3 in
Gram-positive bacteria

Molnar et al. (2004), Kars et al. (2008),
Gyemant et al. (2006)

Najar et al. (2010)

(2004), Limtrakul et al.
Zhou et al.
(2007), Hou et al. (2008), Lu et al. (2012)

Wesolowska et al. (2009)

Gyemant et al. (2005)

Ye et al. (2009)
Zhang et al. (2004), Leslie et al. (2001),
Perez-Victoria et al. (1999), Wesolowska
et al. (2009), Angelini et al. (2010)
Kolaczkowski et al. (1998)

Chung et al. (2005), Zhang et al. (2004)
Tang et al. (2003)

Molnár et al. (2008), Gyemant et al.
(2005), Zhou et al. (2004), Zhang et al.
(2004), Critchﬁeld et al. (1994), de Wet
et al. (2001)
Stermitz et al. (2002)

Molnár et al. (2008)

Chung et al. (2005), Zhang et al. (2004),
Cooray et al. (2004)
An et al. (2011)

Yoo et al. (2007)
Chusri et al. (2009)

Martins et al. (2010), Zhang et al. (2004),
Zhu et al. (2001), Gyemant et al. (2005),
Mei et al. (2004), Wei et al. (2003)

(Continued)

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 5

Wink et al.

Table 2 | Continued

Inhibition of ABC transporter

Natural product

Occurrence

Activities

Reference

Fisetin

Several species

2, 9 in breast cancer cells; 4 in
MES-SA/DX5 cells; substrate for
Yorlp transporters in yeast
Saccharomyces cerevisiae
1, 2, 10

Formononetin and other
isoﬂavones
Galangin

Several species of Fabaceae

Several plant families

2 (biphasic action); 10

Genistein and derivatives

Several species of Fabaceae

1, 2, 9, 10

Naringin, naringenin, and
derivatives

Euphorbia lagascae, Euphorbia
tuckeyana (Euphorbiaceae);
Citrus hybrids (Rutaceae)

Hesperidin, neohesperidin,
nobiletin, Tangeretin
Icariin

Isobavachalcone

Kaempferol, morin, taxifolin,
spiraeoside, and related
ﬂavonoids
Luteolin and its glycosides

Mangiferin, norathyriol, and
other xanthones

Pentagalloylglucose
(gallotannin)
Phloretin, phloridzin

Plagiochin E

Quercetin,
3(cid:2),4(cid:2),7-trimethoxyquercetin,
quercetagetin, hesperetin,
isoquercitrin, myricetin, and
derivatives

Citrus jambhiri, Citrus pyriformis
(Rutaceae)
Epimedium grandiﬂorum
(Berberidaceae)
Dorstenia barteri (Moraceae)

Several plants

1, 9

1, 5

Inhibits efﬂux pump in
Gram-negative bacteria
2 (biphasic action); 1 and OCT, 9, 10

Several plants

1, 9, 10

Mangifera indica (Anacardiaceae)

Modulate the function of
MDR1/P-glycoprotein (P-gp ABCB1)
multidrug transporter. (biphasic
action)
1, 9, 10; substrate for MDR1 in
Plasmodium falciparum

Several species

1 in MDR KB-C2 cells

Several species

1, 9

Marchantia polymorpha
(Marchantiaceae)
Several species

Reverses the efﬂux pump in
Candida albicans
1 and OCT in MDR cancer cells; 9,
10; substrate for Yorlp in yeast
Saccharomyces cerevisiae
substrate for MDR1 in Plasmodium
falciparum.

7, 9
1

1 and OCT; substrate of MDR in
Plasmodium falciparum

Resveratrol
Rotenone

Rutin

Several plants
Derris spp., Tephrosia spp.,
Lonchocarpus spp. (Fabaceae)
Several species

Chung et al.
et al. (1998), Angelini et al. (2010)

(2005), Kolaczkowski

Molnár et al. (2008), Gyemant et al.
(2005)
Zhou et al. (2004), Critchﬁeld et al.
(1994), de Wet et al. (2001)
Zhang et al.
(2004), Taur and
Rodriguez-Proteau (2008), Leslie
et al.
(2001), Versantvoort et al.
(1994, 1996)
El-Readi et al. (2010), Zhang et al.
(2004), Ofer et al. (2005)
Liu et al. (2009)

Kuete et al. (2010)

Zhou et al.
(2004), Zhang et al.
(2004), deWet et al. (2001), Gyemant
et al. (2005)
Zhang et al.
(2004)
[8, 34, 35] Najar et al. (2010), Chieli
et al. (2010)

(2004), Nissler et al.

Chung et al.
(2005), Zhang et al.
(2004), Ofer et al.
(2006), Leslie
et al.
(2001), Perez-Victoria et al.
(1999), de Castro et al. (2007, 2008),
Wesolowska et al.
(2007), Duarte
et al. (2010)
Kitagawa et al. (2007)

Molnár et al. (2008), Zhang and Mor-
ris (2003), Zhang et al. (2004), Gye-
mant et al. (2005)
Guo et al. (2008)

(2007), Leslie et al.

Scambia et al. (1994), Kolaczkowski
et al. (1998), Shapiro and Ling (1997),
Conseil et al. (1998), Cooray et al.
(2005), Ohtani
(2004), Ofer et al.
et al.
(2001),
Zhang et al. (2004)
Cooray et al. (2004)
Molnár et al. (2008), Gyemant et al.
(2005)
Ofer et al. (2005, 2006), Foster et al.
(2001), Perez-Victoria et al. (1999)

(Continued)

Frontiers in Microbiology | Fungi and Their Interactions

April 2012 | Volume 3 | Article 130 | 6

Wink et al.

Table 2 | Continued

Inhibition of ABC transporter

Natural product

Occurrence

Activities

Reference

Silymarin (isosilybin,
silychristin, silydianin, silybin)

Silybum marianum (Asteraceae)

1, 4, 5, 9 in cancer cells

Platanus orientalis (Platanaceae),
Herissantia tiubae (Malvaceae)
Sasa borealis (Gramineae)

Onychium japonicum
(Sinopteridaceae)

5; inhibits (NorA) efﬂux protein in
Staphylococcus aureus
3 in adriamycin-resistant
MCF-7/ADR cells
3 in MCF-7/ADR and Bel-7402/5-Fu
cells

Zhou et al. (2004), Agarwal et al.
(2006), Zhang and Morris (2003),
Zhang et al. (2004), Trompier et al.
(2003)
Falcao-Silva et al. (2009)

Jeong et al. (2007)

Li et al. (2011a)

Quinones, anthraquinones, naphthoquinones
Aloe-emodin

Tiliroside

Tricin

3(cid:2),4(cid:2),6-Trihydroxy-2,4-
dimethoxy-3-(3(cid:2)(cid:2),4(cid:2)(cid:2)-
dihydroxybenzyl) chalcone,
and derivatives
3,5,4(cid:2)-Trimethoxy-trans-
stilbene

Diospyrone (a
naphthoquinone)
Emodin

Rhein

Lignans
Syringaresinol

Coumarins and furanocoumarins
Bergamottin,
6(cid:2),7(cid:2)-dihydroxybergamottin,
6(cid:2),7(cid:2)-epoxybergamottin
Alkaloids
Acronycine
Arborinine, evoxanthine
Berbamine
Berberine

Camptothecin

Canthin-6-one,
8-hydroxy-canthin-6-one,
5(zeta)-hydroxy-octadeca-6(E)-
8(Z)-dienoic
acid
Capsaicin

Catharanthine

Dalea versicolor (Fabaceae)

Rheum palmatum
(Polygonaceae); Aloe spp.
(Asphodelaceae)
Diospyros canaliculata
(Ebenaceae)
Rheum palmatum
(Polygonaceae)
Rheum palmatum
(Polygonaceae)

Enhances the antimicrobial effect of
berberine against NorA S. aureus
mutant strain

Belofsky et al. (2004)

2

Cui et al. (2008)

Inhibits efﬂux pump in
Gram-negative bacteria
2; synergistic antimicrobial effect
with ampicillin or oxacillin in MRSA
2, 4

Kuete et al. (2010)

Lee et al. (2010), Cui et al. (2008)

Cui et al. (2008), van Gorkom et al.
(2002)

Sasa borealis (Gramineae)

1 in adriamycin-resistant
MCF-7/ADR cells

Jeong et al. (2007)

Citrus hybrids (Rutaceae)

1

de Castro et al. (2007, 2008)

Bauerella australiana
Ruta graveolens (Rutaceae)
Berberis sp. (Berberidaceae)
Hydrastis canadensis
(Ranunculaceae)

Camptotheca acuminata
(Nyssaceae)

Allium neapolitanum
(Amaryllidaceae),
(Simaroubaceae), (Rutaceae)

Capsicum frutescens
(Solanaceae)

2
1, 5 in cancer cells
2 in BBB and in Caco2 cells
1, 2, 2 in BBB; 8 (bacteria) 2 in
vascular smooth muscle cells
(VSMCs)
Substrate for ABC2 transporter in
Botrytis cinerea; for PMR5 in
Penicillium digitatum, AtrBp in
Aspergillus nidulans; 11
Inhibits Mycobacterium,
methicillin-resistant Staphylococcus
aureus (MRSA); and a MDR strain
of S. aureus

Dorr et al. (1989)
Rethy et al. (2008)
He and Liu (2002)
Severina et al. (2001), He and Liu
(2002), Efferth et al. (2005), Suzuki
et al. (2010)
Mattern et al.
(2005), Nakaune et
Andrade et al. (2000)

(1993), Lee et al.
(2002),

al.

O’Donnell and Gibbons (2007)

2, 4

Okura et al. (2010)

2, 4 (vinblastine) in CEM/VLB1K
cells

Beck et al.
(1988)

(1988), Zamora et al.

(Continued)

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 7

Wink et al.

Table 2 | Continued

Inhibition of ABC transporter

Natural product

Occurrence

Activities

Reference

Stephania cepharantha
(Menispermaceae)
Zanthoxylum clava-herculis
(Rutaceae)
Cinchona pubescens (Rubiaceae)

4 (doxorubicin and vincristine)

Reversal of drug resistance in methicillin-
resistant Staphylococcus aureus (MRSA)
4

2

(2005), Katsui et al.

Ikeda et al.
(2004), Nakajima et al. (2004)
Gibbons et al. (2003)

(2000), Genne et al.

Solary et al.
(1994), Lee et al. (2011)
Elsinga et al. (2004)

Cepharanthine

Chelerythrine

Cinchonine, hydrocinchonine,
quinidine
Colcemid, colchicine

Conoduramine
Coptisine

8-Oxocoptisine
Coronaridine, heyneanine
dippinine B and C
Cycleanine

Cyclopamine
Dauriporphine

Emetine

Ergotamine

Fangchinoline

Galanthamine

Gamma-fagarine

Glaucine
Harmine

Homoharringtonine,
cephalotaxine
Hydrastine

Ibogaine

Indole-3-carbinol

Insularine, insulanoline

Kopsamine, pleiocarpine,
lahadinine A, kopsiﬂorine
Lobeline
5-Methoxyhydnocarpine,
pheophorbide A

N-trans-feruloyl
4(cid:2)-O-methyldopamine

Colchicum autumnale
(Colchicaceae)
Peschiera laeta (Apocynaceae)
Several species of
Ranunculaceae; Berberidaceae
Coptis japonica (Ranunculaceae)
Tabernanthe iboga
(Apocynaceae)
Synclisia scabrida
(Menispermaceae)
Veratrum spp. (Melanthiaceae)
Sinomenium acutum
(Menispermaceae)
Psychotria ipecacuanha
(Rubiaceae)
Claviceps purpurea
(Clavicipitaceae)
Stephania tetrandra
(Menispermaceae)
Galanthus nivalis
(Amaryllidaceae)
Phellodendron amurense
(Rutaceae)
Glaucium ﬂavum (Papaveraceae)
Peganum harmala
(Zygophyllaceae)
Cephalotaxus harringtonia
(Cephalotaxaceae)
Hydrastis canadensis
(Ranunculaceae)
Tabernanthe iboga
(Apocynaceae)
Many species of Brassicaceae

Antizoma miersiana
(Menispermaceae)
Kopsia dasyrachis (Apocynaceae)

Lobelia inﬂata (Campanulaceae)
Hydnocarpus kurzii
(Flacourtiaceae), Berberis spp.
(Berberidaceae)
Mirabilis jalapa (Nyctaginaceae)

2, 4 in KB cells
2 in vascular smooth muscle cells
(VSMCs)
1 in MES-SA/DX5 and HCT15 cells
4 in vincristine-resistant KB cells

You et al. (1994)
Suzuki et al. (2010)

Min et al. (2006b)
Kam et al. (2004)

6 in MCF-7/Adr and KBv200 cells

Tian and Pan (1997)

1, 3
1 in MES-SA/DX5 and HCT15 cells

Lavie et al. (2001)
Min et al. (2006a)

2, 11

1 in MDR cells

Möller et al. (2006)

Yasuda et al. (2002)

Reduces resistance to paclitaxel and
actinomycin D in HCT15 cells
1 at the BBB

Choi et al. (1998), Wang et al. (2005)

Namanja et al. (2009)

1 MDR cancer cells

Min et al. (2007)

1, 2
9

2, 11

2

5, 9

Downregulation of upregulated P-gp;
dietary adjuvant in MDR cancer treatment
9 in MCF-7/Adr and KBv200 cells

4

Ma and Wink (2009)
Ma and Wink (2010)

Zhou et al. (1995), Efferth et al. (2003)

Etheridge et al. (2007)

Tournier et al. (2010)

Arora and Shukla (2003)

Tian and Pan (1997)

Kam et al. (1998)

4 in tumor cells
Inhibitor of NorA MDR pump in
Staphylococcus aureus

Ma and Wink (2008)
Stermitz et al. (2000a,b, 2001), Guz
et al. (2001)

Inhibits growth of Staphylococcus aureus
overexpressing the multidrug efﬂux
transporter NorA

Michalet et al. (2007)

(Continued)

Frontiers in Microbiology | Fungi and Their Interactions

April 2012 | Volume 3 | Article 130 | 8

Wink et al.

Table 2 | Continued

Inhibition of ABC transporter

Natural product

Occurrence

Activities

Reference

Oxyberberine, canthin-6-one,
4-methoxy-N-methyl-2-
quinolone,
oxypalmatine
Paclitaxel
Palmatine

Piperine

Quinine

Rescinnamine

Reserpine

Roemerine

Rutaecarpine

Sanguinarine

Stemocurtisine,
oxystemokerrine

Tetrandrine

Phellodendron amurense
(Rutaceae)

Taxus spp. (Taxaceae)
Several species of
Ranunculaceae; Berberidaceae
Piper nigrum (Piperaceae)

Cinchona pubescens (Rubiaceae)

Rauvolﬁa serpentina
(Apocynaceae)
Rauvolﬁa serpentina
(Apocynaceae)

Annona senegalensis
(Annonaceae)
Evodia rutaecarpa (Rutaceae)

Sanguinaria canadensis
(Papaveraceae)
Stemona aphylla and S. burkillii
(Stemonaceae)

Stephania tetrandra
(Menispermaceae)

Thaliblastine

Thalictrum spp. (Ranunculaceae)

Tomatidine

Trisphaeridine, pretazettine,
2-O-acetyllycorine,
risperidone
Vasicine acetate, 2-acetyl
benzylamine
Veralosinine, veranigrine

Vincristine, Vinblastine

Vindoline

Solanum lycopersicum
(Solanaceae)
Several species of
Amaryllidaceae

Adhatoda vasica. (Acanthaceae)

Veratrum lobelianum, Veratrum
nigrum (Melanthiaceae)
Catharanthus roseus
(Apocynaceae)

1 in MDR cancer cells

Min et al. (2007)

2
2 in vascular smooth muscle cells
(VSMCs); 8 (bacteria)
1, 2, 3, 9 in cancer cells; inhibition
of overexpressed mycobacterial
putative efﬂux protein (Rv1258c)
2; 4

3 of vinblastine; induces MDR1 and
p-gp expression
8 in bacteria; 3 in
methicillin-resistant Staphylococcus
aureus (MRSA) strains (NorA MDR
pump); 2; 3 of vinblastine in
CEM/VLB1K cells
2; 4

6 in p-gp overexpressing
CEM/ADR5000 cells
4

P-gp modulator, enhance the
cytotoxicity of vinblastine,
paclitaxel, and doxorubicin in KB-V1
cells
1; reduces resistance to paclitaxel
and actinomycin D in HCT15 cells; 4
in MDR mice; 6 (in vitro and in vivo);
4in cancer patients treated with
doxorubicin, etoposide, and
cytarabine
Reverses MDR by decreasing the
overexpression of P-gp in
MCF-7/Adr cells
1,2

1 and 3 in L5178 MDR mouse
lymphoma cells

Inhibit Mycobacterium tuberculosis
and a MDR strain
1 and 3 against doxorubicin

Distefano et al. (1997)
Severina et al. (2001), Suzuki et al.
(2010)
Han et al. (2008), Bhardwaj et al.
(2002), Li et al. (2011b), Sharma et al.
(2010)
Genne et al. (1994), Zamora et al.
(1988)
Bhat et al. (1995)

Beck et al. (1988), Gibbons and Udo
(2000), Markham et al. (1999)

You et al. (1995)

Lee et al. (1995), Adams et al. (2007)

Ding et al. (2002), Weerasinghe et al.
(2006)
Chanmahasathien et al. (2011)

Choi et al. (1998), Xu et al. (2006),
Zhu et al. (2005), Fu et al. (2002,
2004)

Chen and Waxman (1995), Chen
et al. (1993, 1996)

Lavie et al. (2001)

Zupko et al. (2009)

Ignacimuthu and Shanmugam (2010)

Ivanova et al. (2011)

2; 2 in BBB; 11

He and Liu (2002), Hu et al. (1995)

2; reversal of vinblastine resistance
in a MDR human leukemic cell line
and CEM/VLB1K cells

Beck et al. (1988)

(Continued)

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 9

Wink et al.

Table 2 | Continued

Inhibition of ABC transporter

Natural product

Occurrence

Activities

Reference

Voacamine

Yohimbine

Peschiera laeta, Peschiera
fuchsiaefolia (Apocynaceae)

Rauwolﬁa serpentina
(Apocynaceae)

1, 2; 2 in BBB; reversal of
vinblastine; and doxorubicin
resistance in MDR cancer cells by
binding to P-glycoprotein
Reversal of vinblastine resistance in
a MDR human leukemic cell line
and CEM/VLB 100 cells

You et al.
(2003, 2005)

(1994), Meschini et al.

Zamora et al.
(1995)

(1988), Bhat et al.

Activities: 1: inhibits p-gp; 2: p-gp substrate; 3: reversal of MDR; 4: reversal of p-gp mediated MDR; 5: inhibition of MDR1 gene. 6: p-gp modulation in cancer cells;
7: induction of apoptosis; 8: substrate for ABC transporter; 9: blocks BCRP and increases in mitoxantrone accumulation; 10: MRP1 inhibitor; 11: induction of MDR
overexpression.

Among the structurally heterogenous group of alkaloids, a
large number of the more lipophilic substances from the classes
of isoquinoline, protoberberine, quinoline, indole, monoterpene
indole, and steroidal alkaloids (Table 2) can serve as substrates
whereas the more polar alkaloids with a tropane, quinolizidine,
piperidine, and pyrrolizidine skeleton do not bind to ABC trans-
porters (Wink, 2007). Similar to the situation of terpenoids, the
active alkaloids probably function as competitive inhibitors of P-
gp and BCRP in cancer cells, and NorA in bacteria and fungi
(Table 2).

It is remarkable on the ﬁrst sight that also quite a large
number of more polar phenolic SM (phenolic acids, ﬂavonoids,
catechins, chalcones, xanthones, stilbenes, anthocyanins, tan-
nins, anthraquinones, and naphthoquinones) inhibit P-gp, MRP1,
BCRP, and OATP in cancer cells with MDR. Some of them can
reverse MDR when given in combination with cytotoxic agents
(Table 2). Bacteria and fungi appear to be sensitive as well (Guz
et al., 2001; Falcao-Silva et al., 2009). Some of these pheno-
lics are lipophilic enough to be competitive inhibitors of ABC
transporters.

Polyphenols are exciting tethering compounds of proteins.
They can effectively interact directly with proteins by forming
hydrogen and ionic bonds with amino acid side chains. They
can thus interfere with the 3D structure of proteins (conforma-
tion) and inhibit their activities (details in Wink, 2008b; Wink
and Schimmer, 2010). We speculate therefore, that the inhibition
seen in polyphenols is caused by a direct binding and complex
formation (not necessarily the active side) of ABC transporters.
Since many polyphenols have no or very low toxicity (e.g., many
of them are ingredients of our food, such as ﬂavonoids or tannins),

they might be excellent candidates as reversal agents, both in
chemotherapy and in agriculture.

We have focused on ABC transporters in this review. But as
mentioned above, resistance can be due to other mechanisms
as well and is often multifactorial. Faria et al. (2011) and Kim
et al. (2007, 2010) have successfully employed thymol (a pheno-
lic monoterpene), salicyl aldehyde, and the alkaloid berberine to
enhance the activity of fungicides in Candida, Aspergillus, Penicil-
lium, and Cryptococcus. These experimental data can be regarded
as a proof of concept that plant secondary products can be interest-
ing candidates for chemosensitization (even if they not interfere
with ABC transporters) of pathogenic fungi in agriculture and
food technology to improve the fungicidal activity of certain
fungicides.

CONCLUSION
This review summarizes the evidence that selected SM of plants
can be interesting candidates to inhibit ABC transporters in
MDR cancer cells or to chemosensitize pathogenic fungi and
other microbes for treatment with antimicrobial agents. Whereas
lipophilic terpenoids and alkaloids appear to be substrates of P-gp,
MRP1, or BCRP and thus competitive inhibitors, the more polar
phenolic compounds (ﬂavonoids, tannins, quinones) can bind to
the transporter proteins and inhibit their activity by disturbing
protein conformation. A combination of a cytotoxic agent, antibi-
otic, or fungicide with a natural chemosensitizer (not necessarily
an inhibitor of ABC transporters) might provide an interesting
strategy to overcome MDR in cancer patients and to improve
antibiotic or antifungal efﬁcacy in medicine, agriculture, or food
industry.

REFERENCES
Adams, M., Mahringer, A., Kunert,
O., Fricker, G., Efferth, T., and
Bauer, R. (2007). Cytotoxicity and
p-glycoprotein modulating effects of
quinolones and indoloquinazolines
from the Chinese herb Evodia rutae-
carpa. Planta Med. 73, 1554–1557.

Agarwal, R., Agarwal, C.,

Ichikawa,
H., Singh, R. P., and Aggarwal, B.
B. (2006). Anticancer potential of

silymarin, from bench to bed side.
Anticancer Res. 26, 4457–4498.

Ambudkar, S. V., Dey, S., Hrycyna, C.
A., Ramachandra, M., Pastan, I., and
Gottesman, M. M. (1999). Biochem-
ical, cellular, and pharmacological
aspects of the multidrug transporter.
Annu. Rev. Pharmacol. Toxicol. 39,
361–398.

An, G., Wu, F., and Morris, M. E.
(2011). 5,7-Dimethoxyﬂavone and

in combina-
multiple ﬂavonoids
the ABCG2-mediated
tion alter
tissue
of mitox-
antrone in mice. Pharm. Res. 28,
1090–1099.

distribution

Andrade, A. C., Del Sorbo, G., Van
Nistelrooy, J. G., and Waard, M. A.
(2000). The ABC transporter AtrB
from Aspergillus nidulans mediates
resistance
classes
fungicides and some natural
of

to all major

toxic compounds. Microbiology 146,
1987–1997.

Angelini, A., Di Ilio, C., Castellani,
M. L., Conti, P., and Cuccurullo,
F. (2010). Modulation of multidrug
resistance p-glycoprotein activity by
ﬂavonoids and honokiol in human
doxorubicin- resistant sarcoma cells
(MES-SA/DX-5),
implications for
sedatives as chemosensi-
natural
tizing agents
therapy.

in cancer

Frontiers in Microbiology | Fungi and Their Interactions

April 2012 | Volume 3 | Article 130 | 10

Wink et al.

Inhibition of ABC transporter

J. Biol. Regul. Homeost. Agents 24,
197–205.

Annereau, J. P., Szakács, G., Tucker, C. J.,
Arciello, A., Cardarelli, C., Collins, J.,
Grissom, S., Zeeberg, B. R., Reinhold,
W., Weinstein, J. N., Pommier, Y.,
Paules, R. S., and Gottesman, M. M.
(2004). Analysis of ATP-binding cas-
sette transporter expression in drug-
selected cell lines by a microarray
dedicated to multidrug resistance.
Mol. Pharmacol. 66, 1397–1405.

Arora, A., and Shukla, Y. (2003). Mod-
ulation of vinca-alkaloid induced P-
glycoprotein expression by indole-3-
carbinol. Cancer Lett. 189, 167–173.
Beck, W. T., Cirtain, M. C., Glover, C.
J., Felsted, R. L., and Safa, A. R.
(1988). Effects of indole alkaloids
on multidrug resistance and labeling
of P-glycoprotein by a photoafﬁnity
vinblastine. Biochem.
analog of
Biophys.
153,
959–966.

Commun.

Res.

Belofsky, G., Percivill, D., Lewis, K.,
Tegos, G. P., and Ekart, J. (2004).
Phenolic metabolites of Dalea versi-
color that enhance antibiotic activity
against model pathogenic bacteria. J.
Nat. Prod. 67, 481–484.

Berek, L., Szabo, D., Petri, I. B., Shoyama,
Y., Lin, Y. H., and Molnar, J. (2001).
Effects of naturally occurring glu-
cosides, solasodine glucosides, gin-
senosides and parishin derivatives
on multidrug resistance of
lym-
phoma cells and leukocyte func-
tions. In vivo 15, 151–156.

Bhardwaj, R. K., Glaeser, H., Becque-
mont, L., Klotz, U., Gupta, S. K.,
and Fromm, M. F. (2002). Piperine,
a major constituent of black pepper,
inhibits human P-glycoprotein and
CYP3A4. J. Pharmacol. Exp. Ther.
302, 645–650.

Bhat, U. G., Winter, M. A., Pearce, H. L.,
and Beck, W. T. (1995). A structure-
function relationship among reser-
pine and yohimbine analogues in
their ability to increase expression
of mdr1 and P-glycoprotein in a
human colon carcinoma cell
line.
Mol. Pharmacol. 48, 682–689.

Brooks, T. A., Minderman, H.,
O’Loughlin, K. L., Pera, P., Ojima,
I., Baer, M. R., and Bernacki, R. J.
(2003). Taxane-based reversal agents
modulate drug resistance mediated
by P-glycoprotein, multidrug resis-
tance protein, and breast cancer
resistance protein. Mol. Cancer Ther.
2, 1195–1205.

Cavet, M. E., West, M., and Simmons,
N. L. (1996). Transport and epithe-
lial secretion of the cardiac glycoside,
digoxin, by human intestinal epithe-
lial (Caco-2) cells. Br. J. Pharmacol.
118, 1389–1396.

Chanmahasathien, W., Ampasavate, C.,
Greger, H., and Limtrakul, P. (2011).
Stemona alkaloids, from traditional
Thai medicine, increase chemosen-
sitivity via P-glycoprotein-mediated
multidrug resistance. Phytomedicine
18, 199–204.

Chauffert, B., Pelletier, H., Corda, C.,
Solary, E., Bedenne, L., Caillot, D.,
and Martin, F. (1990). Potential
usefulness of quinine to circum-
vent the anthracycline resistance in
clinical practice. Br. J. Cancer 62,
395–397.

Chen, G., Ramachandran, C., and Kris-
han, A.
(1993). Thaliblastine, a
plant alkaloid, circumvents mul-
tidrug resistance by direct binding
to P-glycoprotein. Cancer Res. 53,
2544–2547.

Chen, G., Teicher, B. A., and Frei,
E. (1996). Differential interactions
of Pgp inhibitor thaliblastine with
adriamycin, etoposide,
taxol and
anthrapyrazole CI941 in sensi-
tive and multidrug-resistant human
MCF-7 breast cancer cells. Anti-
cancer Res. 16, 3499–3505.

Chen, G., and Waxman, D. J. (1995).
Complete reversal by thaliblastine
of 490-fold adriamycin resistance in
multidrug-resistant (MDR) human
breast cancer cells. Evidence that
multiple biochemical changes
in
MDR cells need not correspond
to multiple functional determinants
for drug resistance. J. Pharmacol.
Exp. Ther. 274, 1271–1277.

Chieli, E., Romiti, N., Rodeiro, I., and
Garrido, G. (2010). In vitro mod-
ulation of ABCB1/P-glycoprotein
expression by polyphenols
from
Mangifera indica. Chem. Biol. Inter-
act. 186, 287–294.

Choi, C. H., Kang, G., and Min, Y. D.
(2003). Reversal of P-glycoprotein-
mediated multidrug resistance by
protopanaxatriol ginsenosides from
Korean red ginseng. Planta Med. 69,
235–240.

Choi, S. U., Park, S. H., Kim, K. H.,
Choi, E. J., Kim, S., Park, W. K.,
Zhang, Y. H., Kim, H. S., Jung, N.
P., and Lee, C. O. (1998). The bis-
benzylisoquinoline alkaloids, tetran-
dine and fangchinoline, enhance the
cytotoxicity of multidrug resistance-
related drugs via modulation of P-
glycoprotein. Anticancer Drugs 9,
255–261.

Chung, S. Y., Sung, M. K., Kim, N. H.,
Jang, J. O., Go, E. J., and Lee, H. J.
(2005). Inhibition of P-glycoprotein
by natural products in human breast
cancer cells. Arch. Pharm. Res. 28,
823–828.

Chusri, S., Villanueva, I., Voravuthikun-
chai, S. P., and Davies, J. (2009).

Enhancing antibiotic activity, a strat-
egy to control Acinetobacter infec-
tions. J. Antimicrob. Chemother. 64,
1203–1211.

Conseil, G., Baubichon-Cortay, H.,
Dayan, G., Jault, J. M., Barron, D.,
and Di Pietro, A. (1998). Flavonoids,
a class of modulators with bifunc-
tional interactions at vicinal ATP-
and steroid-binding sites on mouse
P-glycoprotein. Proc. Natl. Acad. Sci.
U.S.A. 95, 9831–9836.

Cooray, H. C., Janvilisri, T., van Veen, H.
W., Hladky, S. B., and Barrand, M.
A. (2004). Interaction of the breast
cancer resistance protein with plant
polyphenols. Biochem. Biophys. Res.
Commun. 317, 269–275.

Critchﬁeld, J. W., Welsh, C. J., Phang,
J. M., and Yeh, G. C. (1994). Mod-
ulation of adriamycin accumula-
tion and efﬂux by ﬂavonoids in
HCT-15 colon cells. Activation of
P-glycoprotein as a putative mech-
anism. Biochem. Pharmacol. 48,
1437–1445.

Cui, X. R., Tsukada, M., Suzuki, N.,
Shimamura, T., Gao, L., Koyanagi,
J., Komada, F., and Saito, S. (2008).
Comparison of the cytotoxic activ-
ities of naturally occurring hydrox-
yanthraquinones and hydroxynaph-
thoquinones. Eur. J. Med. Chem. 43,
1206–1215.

Dantzig, A. H., Law, K. L., Cao, J.,
and Starling, J. J. (2001). Reversal
of multidrug resistance by the P-
glycoprotein modulator, LY335979,
from the bench to the clinic. Curr.
Med. Chem. 8, 39–50.

Dantzig, A. H., Shepard, R. L., Cao, J.,
Law, K. L., Ehlhardt, W. J., Baugh-
man, T. M., Bumol, T., and Starling, J.
J. (1996). Reversal of P-glycoprotein-
mediated multidrug resistance by a
potent cyclopropyldibenzosuberane
modulator, LY335979. Cancer Res.
56, 4171–4179.

de Castro, W. V., Mertens-Talcott, S.,
Derendorf, H., and Butterweck, V.
(2007). Grapefruit juice-drug inter-
actions, grapefruit
juice and its
components inhibit P-glycoprotein
(ABCB1) mediated transport of tal-
inolol in Caco-2 cells. J. Pharm. Sci.
96, 2808–2817.

de Castro, W. V., Mertens-Talcott, S.,
Derendorf, H., and Butterweck, V.
(2008). Effect of grapefruit juice,
naringin, naringenin, and berg-
amottin on the intestinal carrier-
mediated transport of talinolol in
rats.
J. Agric. Food Chem. 56,
4840–4845.

de Lannoy, I. A., and Silverman, M.
(1992). The MDR1 gene product, P-
glycoprotein, mediates the transport
of the cardiac glycoside, digoxin.

Biochem. Biophys. Res. Commun.
189, 551–557.

Jault,

J. M., Daskiewicz,

de Wet, H., McIntosh, D. B., Con-
seil, G., Baubichon-Cortay, H., Krell,
T.,
J.
B., Barron, D., and Di Pietro,
A. (2001). Sequence requirements
of
the ATP-binding site within
the C-terminal nucleotide-binding
domain of mouse P-glycoprotein,
structure-activity relationships for
ﬂavonoid binding. Biochemistry 40,
10382–10391.

Ding, Z., Tang, S. C., Weerasinghe, P.,
Yang, X., Pater, A., and Liepins, A.
(2002). The alkaloid sanguinarine
is effective against multidrug resis-
tance in human cervical cells via
bimodal cell death. Biochem. Phar-
macol. 63, 1415–1421.

Distefano, M., Scambia, G., Ferlini,
C., Gaggini, C., De Vincenzo, R.,
Riva, A., Bombardelli, E., Ojima,
I., Fattorossi, A., Panici, P. B.,
and Mancuso, S.
(1997). Anti-
proliferative activity of a new class
(14beta-hydroxy-10-
of
deacetylbaccatin
derivatives)
on multidrug-resistance-positive
human cancer cells. Int. J. Cancer
72, 844–850.

taxanes

III

Dorr, R. T., Liddil, J. D., Von Hoff,
D. D., Soble, M., and Osborne, C.
K. (1989). Antitumor activity and
murine pharmacokinetics of par-
enteral acronycine. Cancer Res. 49,
340–344.

Duarte, N., Gyemant, N., Abreu, P.
M., Molnar, J., and Ferreira, M. J.
(2006). New macrocyclic lathyrane
diterpenes, from Euphorbia lagascae,
as inhibitors of multidrug resistance
of tumour cells. Planta Med. 72,
162–168.

Duarte, N., Lage, H., Abrantes, M.,
and Ferreira, M. J. (2010). Phe-
nolic compounds as selective anti-
neoplasic agents against multidrug-
resistant human cancer cells. Planta
Med. 76, 975–980.

J., and Ferreira, M.

Duarte, N., Ramalhete, C., Varga, A.,
Molnar,
J.
(2009). Multidrug resistance mod-
ulation and apoptosis induction of
cancer cells by terpenic compounds
isolated from Euphorbia species.
Anticancer Res. 29, 4467–4472.

Efferth, T., Chen, Z., Kaina, B., and Ag,
W. (2005). Molecular determinants
of response of tumor cells to berber-
ine. Cancer Genomics Proteomics 2,
115–123.

Efferth, T., Sauerbrey, A., Halatsch, M.
E., Ross, D. D., and Gebhart, E.
(2003). Molecular modes of action
of cephalotaxine and homoharring-
tonine from the coniferous
tree
Cephalotaxus hainanensis in human

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 11

Wink et al.

Inhibition of ABC transporter

tumor cell lines. Naunyn Schmiede-
bergs Arch. Pharmacol. 367, 56–67.

El-Readi, M. Z., Hamdan, D., Farrag, N.,
El-Shazly, A., and Wink, M. (2010).
Inhibition of P-glycoprotein activ-
ity by limonin and other secondary
metabolites
species
in human colon and leukaemia
cell
lines. Eur. J. Pharmacol. 626,
139–145.

from Citrus

Elsinga, P. H., Hendrikse, N. H.,
Bart,
J., Vaalburg, W., and van
Waarde, A. (2004). PET studies
on P-glycoprotein function in the
blood-brain barrier, how it affects
uptake and binding of drugs within
the CNS. Curr. Pharm. Des. 10,
1493–1503.

Etheridge, A. S., Black, S. R., Patel,
P. R., So, J., and Mathews, J. M.
(2007). An in vitro evaluation of
cytochrome P450 inhibition and P-
glycoprotein interaction with gold-
enseal, Ginkgo biloba, grape seed,
milk thistle, and ginseng extracts and
their constituents. Planta Med. 73,
731–741.

Falcao-Silva, V. S., Silva, D. A., Souza
Mde, F., and Siqueira-Junior, J. P.
(2009). Modulation of drug resis-
tance in Staphylococcus aureus by
a kaempferol glycoside from Heris-
santia tiubae (Malvaceae). Phytother.
Res. 23, 1367–1370.

Faria, N. C. G., Kim, J. H., Goncalves, L.,
Martins, M., Chan, K. L., and, Camp-
bell, B. (2011). Enhanced activity of
antifungal drugs using natural phe-
nolics against yeast strains of Can-
dida and Cryptococcus. Lett. Appl.
Micobiol. 5, 506–513.

Fernandes, J., Castilho, R. O., da Costa,
M. R., Wagner-Souza, K., Coelho
Kaplan, M. A., and Gattass, C. R.
(2003). Pentacyclic triterpenes from
Chrysobalanaceae species, cytotoxi-
city on multidrug resistant and sen-
sitive leukemia cell lines. Cancer Lett.
190, 165–169.

Foster, B. C., Foster, M. S., Vanden-
hoek, S., Krantis, A., Budzinski, J. W.,
Arnason, J. T., Gallicano, K. D., and
Choudri, S. (2001). An in vitro eval-
uation of human cytochrome P450
3A4 and P-glycoprotein inhibition
by garlic. J. Pharm. Pharm. Sci. 4,
176–184.

Fu, L., Liang, Y., Deng, L., Ding, Y.,
Chen, L., Ye, Y., Yang, X., and
Pan, Q. (2004). Characterization of
tetrandrine, a potent inhibitor of
P-glycoprotein-mediated multidrug
resistance. Cancer Chemother. Phar-
macol. 53, 349–356.

Fu, L. W., Zhang, Y. M., Liang, Y. J.,
Yang, X. P., and Pan, Q. C. (2002),
The multidrug resistance of tumour
cells was reversed by tetrandrine

in vitro and in xenografts derived
from human breast adenocarcinoma
MCF-7/adr cells. Eur. J. Cancer 38,
418–426.

Genne, P., Dimanche-Boitrel, M. T.,
Mauvernay, R. Y., Gutierrez, G.,
Duchamp, O., Petit, J. M., Martin,
F., and Chauffert, B. (1992). Cin-
chonine, a potent efﬂux inhibitor to
circumvent anthracycline resistance
in vivo. Cancer Res. 52, 2797–2801.

Genne, P., Duchamp, O., Solary, E.,
Pinard, D., Belon, J. P., Dimanche-
Boitrel, M. T., and Chauffert, B.
(1994). Comparative
effects of
quinine and cinchonine in reversing
multidrug resistance on human
leukemic
line K562/ADM.
Leukemia 8, 160–164.

cell

Gibbons, S., Leimkugel, J., Oluwatuyi,
M., and Heinrich, M. (2003). Activ-
ity of Zanthoxylum clava-herculis
extracts against multi-drug resistant
methicillin-resistant Staphylococcus
aureus (mdr-MRSA). Phytother. Res.
17, 274–275.

Gibbons, S., and Udo, E. E. (2000).
The effect of reserpine, a modula-
tor of multidrug efﬂux pumps, on
the in vitro activity of tetracycline
against clinical
isolates of methi-
cillin resistant Staphylococcus aureus
(MRSA) possessing the tet(K) deter-
minant. Phytother. Res. 14, 139–140.
Gillet, J. P., Efferth, T., Steinbach, D.,
Hamels, J., de Longueville, F., Bert-
holet, V., and Remacle, J. (2004).
Microarray-based detection of mul-
tidrug resistance in human tumor
cells by expression proﬁling of ATP-
binding cassette transporter genes.
Cancer Res. 64, 8987–8993.

Gottesman, M. M. (2002). Mechanisms
of cancer drug resistance. Annu. Rev.
Med. 53, 615–627.

Guengerich, F. P. (2001). Uncommon
P450-catalyzed reactions. Curr. Drug
Metab. 2, 93–115.

Guo, X. L., Leng, P., Yang, Y., Yu, L.
G., and Lou, H. X. (2008). Pla-
giochin E, a botanic-derived pheno-
lic compound, reverses fungal resis-
tance to ﬂuconazole relating to the
efﬂux pump. J. Appl. Microbiol. 104,
831–838.

Guz, N. R., Stermitz, F. R., Johnson, J.
B., Beeson, T. D., Willen, S., Hsiang,
J., and Lewis, K. (2001). Flavono-
lignan and ﬂavone inhibitors of
a Staphylococcus aureus multidrug
resistance pump, structure-activity
relationships.
J. Med. Chem. 44,
261–268.

Gyemant, N., Tanaka, M., Antus, S.,
Hohmann,
J., Csuka, O., Man-
doky, L., and Molnar, J. (2005).
In vitro search for synergy between
ﬂavonoids
on

epirubicin

and

multidrug-resistant
In vivo 19, 367–374.

cancer

cells.

Gyemant, N., Tanaka, M., Molnar, P.,
Deli, J., Mandoky, L., and Mol-
nar, J. (2006), Reversal of multidrug
resistance of cancer cells in vitro,
modiﬁcation of drug resistance by
selected carotenoids. Anticancer Res.
26, 367–374.

Han, Y., Chin Tan, T. M., and Lim,
L. Y. (2008). In vitro and in vivo
evaluation of the effects of piper-
ine on P-gp function and expres-
sion. Toxicol. Appl. Pharmacol. 230,
283–289.

He, L., and Liu, G. Q. (2002). Effects
of various principles from Chinese
herbal medicine on rhodamine123
accumulation in brain capillary
endothelial cells. Acta Pharmacol.
Sin. 23, 591–596.

Hebestreit, P., and Melzig, M. (2003).
Cytotoxic activity of the seeds from
Agrostemma githago var. githago.
Planta Med. 69, 921–925.

Hohmann, J., Molnar, J., Redei, D.,
Evanics, F., Forgo, P., Kalman, A.,
Argay, G., and Szabo, P. (2002). Dis-
covery and biological evaluation of
a new family of potent modula-
tors of multidrug resistance, rever-
sal of multidrug resistance of mouse
lymphoma cells by new natural jat-
rophane diterpenoids isolated from
Euphorbia species. J. Med. Chem. 45,
2425–2431.

Hou, X. L., Takahashi, K., Tanaka,
K., Tougou, K., Qiu, F., Komatsu,
K., and Azuma, J. (2008). Cur-
cuma drugs and curcumin regulate
the expression and function of P-
gp in Caco-2 cells in completely
opposite ways. Int. J. Pharm. 358,
224–229.

Hu, X. F., Slater, A., Wall, D. M., Kan-
tharidis, P., Parkin, J. D., Cowman,
A., and Zalcberg, J. R. (1995). Rapid
up-regulation of mdr1 expression
by anthracyclines
in a classical
multidrug-resistant cell line. Br. J.
Cancer 71, 931–936.

Hyaﬁl, F., Vergely, C., Du Vignaud,
P., and Grand-Perret, T. (1993).
In vitro and in vivo reversal of
multidrug resistance by GF120918,
an acridonecarboxamide derivative.
Cancer Res. 53, 4595–4602.

Ignacimuthu, S., and Shanmugam, N.
(2010). Antimycobacterial activity
of two natural alkaloids, vasicine
acetate and 2-acetyl benzylamine,
isolated from Indian shrub Adha-
toda vasica Nees. leaves. J. Biosci. 35,
565–570.

Ikeda, R., Che, X. F., Yamaguchi, T.,
Ushiyama, M., Zheng, C. L., Oku-
mura, H., Takeda, Y., Shibayama,
Y., Nakamura, K., and Jeung, H.

C. (2005). Cepharanthine potently
enhances the sensitivity of anti-
cancer agents in K562 cells. Cancer
Sci. 96, 372–376.

Ingelman-Sundberg, M., and Gomez, A.
(2010). The past, present and future
of pharmacoepigenomics. Pharma-
cogenomics 11, 625–662.

Ivanova, A., Serly, J., Christov, V., Stam-
boliyska, B., and Molnar, J. (2011).
Alkaloids derived from genus Ver-
atrum and Peganum of Mongo-
lian origin as multidrug resistance
inhibitors of cancer cells. Fitoterapia
82, 570–575.

Ivanova, A., Serly,

J., Dinchev, D.,
Ocsovszki, I., Kostova, I., and Mol-
nar, J. (2009). Screening of some
saponins and phenolic components
of Tribulus
terrestris and Smilax
excelsa as MDR modulators. In vivo
23, 545–550.

Jeong, Y. H., Chung, S. Y., Han, A. R.,
Sung, M. K., Jang, D. S., Lee, J.,
Kwon, Y., Lee, H. J., and Seo, E.
K. (2007). P-glycoprotein inhibitory
activity of two phenolic compounds,
(-)-syringaresinol and tricin from
Sasa borealis. Chem. Biodivers. 4,
12–16.

Kam, T. S., Sim, K. M., Pang, H. S., Koy-
ano, T., Hayashi, M., and Komiyama,
K. (2004). Cytotoxic effects and
reversal of multidrug resistance by
ibogan and related indole alka-
loids. Bioorg. Med. Chem. Lett. 14,
4487–4489.

Kam, T. S., Subramaniam, G., Sim,
K. M., Yoganathan, K., Koyano,
T., Toyoshima, M., Rho, M. C.,
Hayashi, M., and Komiyama, K.
(1998). Reversal of multidrug resis-
tance (MDR) by aspidofractinine-
type indole alkaloids. Bioorg. Med.
Chem. Lett. 8, 2769–2772.

Kars, M. D., Iseri, O. D., Gunduz,
U., and Molnar, J. (2008). Rever-
sal of multidrug resistance by syn-
thetic and natural compounds in
drug-resistant MCF-7 cell
lines.
Chemotherapy 54, 194–200.

Kashiwada, Y., Nishimura, K., Kuri-
moto, S., and Takaishi, Y. (2011).
New 29-nor-cycloartanes with a 3,4-
seco- and a novel 2,3-seco-structure
from the leaves of Sinocalycanthus
chinensis. Bioorg. Med. Chem. 19,
2790–2796.

Katsui, K., Kuroda, M., Wang, Y.,
Komatsu, M., Himei, K., Takemoto,
M., Akaki, S., Asaumi, J., Kanazawa,
S., and Hiraki, Y. (2004). Cepha-
ranthine enhances adriamycin sensi-
tivity by synergistically accelerating
apoptosis for adriamycin-resistant
osteosarcoma cell lines, SaOS2-AR
and SaOS2 F-AR. Int. J. Oncol. 25,
47–56.

Frontiers in Microbiology | Fungi and Their Interactions

April 2012 | Volume 3 | Article 130 | 12

Wink et al.

Inhibition of ABC transporter

Kim, J. H., Campbell, B. C., Mahoney,
N., Chan, K. L., and Molyneux, R. J.
(2010). Chemosensitization of aﬂa-
toxigenic fungi to antimycin A and
strobilurin using salicylaldehyde, a
volatile natural compound targeting
cellular antioxidation system. Myco-
pathologia 171, 291–298.

Kim, J. H., Campbell, B. C., Mahoney,
N., Chan, K. L., Molyneux, R. J., and
May, G. (2007). Enhanced activity of
strobilurin and ﬂudioxonil by using
berberine and phenolic compounds
to target fungal antioxidative stress
response. Lett. Appl. Microbiol. 45,
134–141.

Kitagawa, S., Nabekura, T., Nakamura,
Y., Takahashi, T., and Kashiwada, Y.
(2007). Inhibition of P-glycoprotein
function by tannic acid and penta-
galloylglucose. J. Pharm. Pharmacol.
59, 965–969.

Kolaczkowski, M., Kolaczowska, A.,
Luczynski, J., Witek, S., and Gof-
feau, A. (1998). In vivo character-
ization of the drug resistance pro-
ﬁle of the major ABC transporters
and other components of the yeast
pleiotropic drug resistance network.
Microb. Drug Resist. 4, 143–158.

Krishnamurthy, P., and Schuetz, J. D.
(2006). Role of ABCG2/BCRP in
biology and medicine. Annu. Rev.
Pharmacol. Toxicol. 46, 381–410.

Kuete, V., Ngameni, B., Tangmouo, J.
G., Bolla, J. M., Alibert-Franco, S.,
Ngadjui, B. T., and Pages, J. M.
(2010). Efﬂux pumps are involved
in the defense of Gram-negative
bacteria against the natural prod-
ucts isobavachalcone and diospy-
rone. Antimicrob. Agents Chemother.
54, 1749–1752.

Kurimoto, S., Kashiwada, Y., Lee, K.
H., and Takaishi, Y. (2011a). Triter-
penes and a triterpene glucoside
from Dysoxylum cumingianum. Phy-
tochemistry 72, 2205–2211.

Kurimoto, S., Kashiwada, Y., Morris-
Natschke, S. L., Lee, K. H., and
Takaishi, Y. (2011b). Dyscusins A-C,
three new steroids from the leaves
of Dysoxylum cumingianum. Chem.
Pharm. Bull. 59, 1303–1306.

effect

Lavie, Y., Harel-Orbital, T., Gafﬁeld,
(2001).
W., and Liscovitch, M.
Inhibitory
steroidal
alkaloids on drug transport and
multidrug
in human
cancer cells. Anticancer Res. 21,
1189–1194.

resistance

of

Lee, S. W., Hwang, B. Y., Kim, S. E., Kim,
H. M., Kim, Y. H., Lee, K. S., Lee,
J. J., and Ro, J.-S. (1995). Isolation
of modulators for multidrug resis-
tance from the fruits of Evodia ofﬁc-
inalis. Korean J. Physiol. Pharmacol.
26, 344–348.

Lee, S. Y., Rhee, Y. H., Jeong, S. J., Lee,
H. J., Jung, M. H., Kim, S. H., Lee, E.
O., and Ahn, K. S. (2011). Hydrocin-
chonine, cinchonine, and qiuinidine
potentiate paclitaxel-induced cyto-
toxicity and apoptosis via multidrug
resistance reversal in MES-SA/DX5
uterine sarcoma cells. Environ. Toxi-
col. 26, 424–431.

Lee,Y.-J.,Yamamoto, K., Hamamoto, H.,
Nakaune, R., and Hibi, T. (2005). A
novel ABC transporter gene ABC2
involved in multidrug susceptibility
but not pathogenicity in rice blast
fungus, Magnaporthe grisea. Pestic.
Biochem. Physiol. 81, 13–23.

Lee, Y. S., Kang, O. H., Choi, J. G.,
Oh, Y. C., Keum, J. H., Kim, S. B.,
Jeong, G. S., Kim, Y. C., Shin, D. W.,
and Kwon, D. Y. (2010). Synergis-
tic effect of emodin in combination
with ampicillin or oxacillin against
methicillin-resistant Staphylococcus
aureus. Pharm. Biol. 48, 1285–1290.
Leslie, E. M., Mao, Q., Oleschuk, C. J.,
Deeley, R. G., and Cole, S. P. (2001).
Modulation of multidrug resistance
protein 1 (MRP1/ABCC1) transport
and ATPase activities by interac-
tion with dietary ﬂavonoids. Mol.
Pharmacol. 59, 1171–1180.

Li, M. C.,Yao, Z., Takaishi,Y., Tang, S. A.,
and Duan, H. Q. (2011a). Isolation
of novel phenolic compounds with
multidrug resistance (MDR) rever-
sal properties from Onychium japon-
icum. Chem. Biodivers. 8, 1112–1120.
Li, S., Lei, Y., Jia, Y., Li, N., Wink, M., and
Ma, Y. (2011b). Piperine, a piperi-
dine alkaloid from Piper nigrum re-
sensitizes P-gp, MRP1 and BCRP
dependent multidrug resistant can-
cer cells. Phytomedicine 19, 83–87.

Limtrakul, P., Chearwae, W., Shukla,
S., Phisalphong, C., and Ambudkar,
S. V. (2007). Modulation of func-
tion of three ABC drug transporters,
P-glycoprotein (ABCB1), mitox-
antrone resistance protein (ABCG2)
and multidrug resistance protein 1
(ABCC1) by tetrahydrocurcumin, a
major metabolite of curcumin. Mol.
Cell. Biochem. 296, 85–95.

Liu, D. F., Li, Y. P., Ou, T. M., Huang,
S. L., Gu, L. Q., Huang, M., and
Huang, Z. S. (2009). Synthesis and
antimultidrug resistance evaluation
of icariin and its derivatives. Bioorg.
Med. Chem. Lett. 19, 4237–4240.

Loo, T. W., and Clarke, D. M. (2005).
Recent progress in understanding
the mechanism of P-glycoprotein-
mediated drug efﬂux. J. Membr. Biol.
206, 173–185.

Lu, J. J., Cai, Y. J., and Ding, J. (2012).
The short-time treatment with cur-
cumin sufﬁciently decreases cell via-
bility, induces apoptosis and copper

enhances these effects in multidrug-
resistant K562/A02 cells. Mol. Cell.
Biochem. 360, 253–260.

Ma, Y., and Wink, M. (2008). Lobeline, a
piperidine alkaloid from Lobelia can
reverse P-gp dependent multidrug
resistance in tumor cells. Phytomed-
icine 15, 754–758.

Ma, Y., and Wink, M. (2009). “Reversal
of multidrug resistance (MDR) by
the isoquinoline alkaloid glaucine,”
in Multiple Drug Resistance, eds A.
Meszaros and G. Balogh (Haup-
pauge: Nova Science Publishers),
1–19.

Ma, Y., and Wink, M. (2010). The beta-
carboline alkaloid harmine inhibits
BCRP and can reverse resistance to
the anticancer drugs mitoxantrone
and camptothecin. Phytother. Res.
24, 146–149.

Madureira, A. M., Spengler, G., Mol-
nar, A., Varga, A., Molnar, J., Abreu,
P. M., and Ferreira, M. J. (2004).
Effect of cycloartanes on reversal
of multidrug resistance and apopto-
sis induction on mouse lymphoma
cells. Anticancer Res. 24, 859–864.

Mahringer, A., and Fricker, G. (2010).
BCRP at
the blood-brain bar-
rier, genomic regulation by 17β-
estradiol. Mol. Pharm. 7, 1835–1847.
Maliepaard, M., van Gastelen, M. A.,
Tohgo, A., Hausheer, F. H., van
Waardenburg, R. C., de Jong, L.
A., Pluim, D., Beijnen, J. H., and
Schellens, J. H. (2001). Circum-
vention of breast cancer resistance
protein (BCRP)-mediated resistance
to camptothecins in vitro using
non-substrate drugs or the BCRP
inhibitor GF120918. Clin. Cancer
Res. 7, 935–941.

Mao, Q., and Unadkat, J. D. (2005).
Role of the breast cancer resistance
protein (ABCG2) in drug transport.
AAPS J. 7, E118–E133.

Markham, P. N., Westhaus, E., Kly-
achko, K., Johnson, M. E., and Ney-
fakh, A. A. (1999). Multiple novel
inhibitors of the NorA multidrug
transporter of Staphylococcus aureus.
Antimicrob. Agents Chemother. 43,
2404–2408.

Martins, A., Vasas, A., Schelz, Z.,
Viveiros, M., Molnar, J., Hohmann,
J., and Amaral, L. (2010). Con-
stituents of Carpobrotus
edulis
inhibit P-glycoprotein of MDR1-
transfected mouse lymphoma cells.
Anticancer Res. 30, 829–835.

Mattern, M. R., Hofmann, G. A., Pol-
sky, R. M., Funk, L. R., McCabe,
F. L., and Johnson, R. K. (1993).
In vitro and in vivo effects of clin-
ically important camptothecin ana-
logues on multidrug-resistant cells.
Oncol. Res. 5, 467–474.

Mei, Y., Qian, F., Wei, D., and Liu, J.
(2004). Reversal of cancer multidrug
resistance by green tea polyphenols.
J. Pharm. Pharmacol. 56, 1307–1314.
Meschini, S., Marra, M., Calcabrini,
A., Federici, E., Galefﬁ, C., and
Arancia, G. (2003). Voacamine, a
bisindolic alkaloid from Peschiera
fuchsiaefolia, enhances the cytotoxic
effect of doxorubicin on multidrug-
resistant tumor cells. Int. J. Oncol. 23,
1505–1513.

Meschini, S., Marra, M., Condello, M.,
Calcabrini, A., Federici, E., Dupuis,
M. L., Cianfriglia, M., and Arancia,
G. (2005). Voacamine, an alkaloid
extracted from Peschiera fuchsiaefo-
lia, inhibits P-glycoprotein action in
multidrug-resistant tumor cells. Int.
J. Oncol. 27, 1597–1603.

Michalet, S., Cartier, G., David, B.,
Mariotte, A. M., Dijoux-Franca,
M. G., Kaatz, G. W., Stavri, M.,
and Gibbons,
(2007). N -
caffeoylphenalkylamide derivatives
as bacterial efﬂux pump inhibitors.
Bioorg. Med. Chem.
17,
1755–1758.

Lett.

S.

Min, Y. D., Choi, S. U., and Lee, K.
R. (2006a). Aporphine alkaloids and
their reversal activity of multidrug
resistance (MDR) from the stems
and rhizomes of Sinomenium acu-
tum. Arch. Pharm. Res. 29, 627–632.
Min, Y. D., Yang, M. C., Lee, K. H.,
Kim, K. R., Choi, S. U., and Lee,
K. R. (2006b). Protoberberine alka-
loids and their reversal activity of
P-gp expressed multidrug resistance
(MDR) from the rhizome of Coptis
japonica Makino. Arch. Pharm. Res.
29,757–761.

Min, Y. D., Kwon, H. C., Yang, M. C.,
Lee, K. H., Choi, S. U., and Lee,
K. R. (2007). Isolation of limonoids
and alkaloids from Phellodendron
amurense and their multidrug resis-
tance (MDR) reversal activity. Arch.
Pharm. Res. 30, 58–63.

Möller, M., Weiss, J., and Wink, M.
(2006). Reduction of cytotoxicity
of the alkaloid emetine through P-
(MDR1/ABCB1)
glycoprotein
in
and
leukaemia cell lines. Planta Med. 72,
1121–1126.

human Caco-2

cells

Molnár,

J., Engi, H., Gyémánt, N.,
Schelz, Z., Spengler, G., Ocsovski, I.,
Szücs, M., Hohmann, J., Szabo, M.,
and Tanács, L. (2008). “Multidrug
resistance reversal in cancer cells by
selected carotenoids, ﬂavonoids and
anthocyanins,” in Bioactive Hetero-
cycles VI, Vol. 15, ed. N. Motohashi
(Berlin: Springer), 133–159. [Topics
in Heterocyclic Chemistry].

Molnar, J., Gyemant, N., Mucsi, I.,
Molnar, A., Szabo, M., Kortvelyesi,

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 13

Wink et al.

Inhibition of ABC transporter

T., Varga, A., Molnar, P., Toth, G.
(2004). Modulation of multidrug
resistance and apoptosis of cancer
cells by selected carotenoids. In vivo
18, 237–244.

Najar, I. A., Sachin, B. S., Sharma, S.
C., Satti, N. K., Suri, K. A., and
Johri, R. K. (2010). Modulation of
P-glycoprotein ATPase activity by
some phytoconstituents. Phytother.
Res. 24, 454–458.

Nakajima, A., Yamamoto, Y., Taura, K.,
Hata, K., Fukumoto, M., Uchinami,
H., Yonezawa, K., and Yamaoka, Y.
(2004). Beneﬁcial effect of cepha-
ranthine on overcoming drug-
resistance of hepatocellular carci-
noma. Int. J. Oncol. 24, 635–645.

Nakaune, R. N., Hamamoto, H. H.,
Imada, J. I., Akutsu, K. A., and Hibi,
T. H. (2002). A novel ABC trans-
porter gene, is involved in multidrug
resistance in the phytopathogenic
fungus Penicillium digitatum. Mol.
Genet. Genomics 267, 179–185.

Namanja, H. A., Emmert, D., Pires,
M. M., Hrycyna, C. A.,
and
Chmielewski, J. (2009). Inhibition
of human P-glycoprotein transport
and substrate binding using a galan-
tamine dimer. Biochem. Biophys. Res.
Commun. 388, 672–676.

as

Nielsen, D., and Skovsgaard, T. (1992).
multidrug
P-Glycoprotein
transporter – a critical-review of
current multidrug resistant cell-
lines. Biochim. Biophys. Acta 1139,
169–183.

Nissler, L., Gebhardt, R., and Berger,
S. (2004). Flavonoid binding to
a multi-drug-resistance transporter
protein, an STD-NMR study. Anal.
Bioanal. Chem. 379, 1045–1049.

Nooter, K., and Stoter, G. (1996). Mol-
ecular mechanisms of multidrug
resistance in cancer chemotherapy.
Pathol. Res. Pract. 192, 768–780.
and Gibbons,

S.
(2007). Antibacterial activity of
two canthin-6-one alkaloids from
Allium neapolitanum. Phytother. Res.
21, 653–657.

O’Donnell, G.,

Ofer, M., Langguth, P., and Spahn-
Langguth, H. (2006). Bidirectional
membrane transport, simulations
of transport inhibition in uptake
studies explain data obtained with
ﬂavonoids. Eur. J. Pharm. Sci. 29,
251–258.

Ofer, M., Wolffram, S., Koggel, A.,
Spahn-Langguth, H., and Langguth,
P.
(2005). Modulation of drug
transport by selected ﬂavonoids:
involvement of P-gp and OCT? Eur.
J. Pharm. Sci. 25, 263–271.

Ohtani, H.,

Ikegawa, T., Honda,
Y., Kohyama, N., Morimoto, S.,
Shoyama, Y., Juichi, M., Naito, M.,

Tsuruo, T., and Sawada, Y. (2007).
Effects of various methoxyﬂavones
on vincristine uptake and multidrug
resistance to vincristine in P-gp-
overexpressing K562/ADM cells.
Pharm. Res. 24, 1936–1943.

Okura, T., Ibe, M., Umegaki, K., Shi-
nozuka, K., and Yamada, S. (2010).
Effects of dietary ingredients on
function and expression of P-
glycoprotein in human intestinal
epithelial cells. Biol. Pharm. Bull. 33,
255–259.

Ordway, D., Hohmann, J., Viveiros, M.,
Viveiros, A., Molnar, J., Leandro,
C., Arroz, M. J., Gracio, M. A.,
and Amaral, L. (2003). Carpobro-
tus edulis methanol extract inhibits
the MDR efﬂux pumps, enhances
killing of phagocytosed S. aureus
and promotes immune modulation.
Phytother. Res. 17, 512–519.

Perez-Victoria, J. M., Chiquero, M. J.,
Conseil, G., Dayan, G., Di Pietro,
A., Barron, D., Castanys, S., and
Gamarro, F.
(1999). Correlation
between the afﬁnity of ﬂavonoids
binding to the cytosolic site of Leish-
mania tropica multidrug transporter
and their efﬁciency to revert parasite
resistance to daunomycin. Biochem-
istry 38, 1736–1743.

Rethy, B., Hohmann, J., Minorics, R.,
Varga, A., Ocsovszki, I., Molnar, J.,
Juhasz, K., Falkay, G., and Zupko,
I. (2008). Antitumour properties of
acridone alkaloids on a murine lym-
phoma cell line. Anticancer Res. 28,
2737–2743.

Robert, J., and Jarry, C. (2003). Mul-
tidrug resistance reversal agents. J.
Med. Chem. 46, 4805–4817.

Rocha Gda, G., Simoes, M., Lucio, K.
A., Oliveira, R. R., Coelho Kaplan,
M. A., and Gattass, C. R. (2007).
Natural triterpenoids from Cecropia
lyratiloba are cytotoxic to both
sensitive and multidrug resistant
leukemia cell
lines. Bioorg. Med.
Chem. 15, 7355–7360.

Rojas, R., Caviedes, L., Aponte, J. C.,
Vaisberg, A. J., Lewis, W. H., Lamas,
G., Sarasara, C., Gilman, R. H., and
Hammond, G. B. (2006). Aegicerin,
the ﬁrst oleanane triterpene with
wide-ranging
antimycobacterial
activity,
from Clavija
procera. J. Nat. Prod. 69, 845–846.

isolated

Scambia, G., Ranelletti, F. O., Panici, P.
B., De Vincenzo, R., Bonanno, G.,
Ferrandina, G., Piantelli, M., Bussa,
S., Rumi, C., and Cianfriglia, M.
(1994). Quercetin potentiates the
effect of adriamycin in a multidrug-
resistant MCF-7 human breast-
cancer cell line, P-glycoprotein as a
possible target. Cancer Chemother.
Pharmacol. 34, 459–464.

Schinkel, A. H., and Jonker, J. W. (2003).
Mammalian drug efﬂux transporters
of the ATP binding cassette (ABC)
family, an overview. Adv. Drug Deliv.
Rev. 55, 3–29.

Severina, I. I., Muntyan, M. S., Lewis, K.,
and Skulachev, V. P. (2001). Trans-
fer of cationic antibacterial agents
berberine, palmatine, and benzalko-
nium through bimolecular planar
phospholipid ﬁlm and Staphylococ-
cus aureus membrane. IUBMB Life
52, 321–324.

Shapiro, A. B., and Ling, V. (1997).
Effect of quercetin on Hoechst 33342
transport by puriﬁed and recon-
stituted P-glycoprotein. Biochem.
Pharmacol. 53, 587–596.

Sharma, S., Kumar, M., Nargotra,
A., Koul, S., and Khan,
I. A.
(2010). Piperine as an inhibitor of
Rv1258c, a putative multidrug efﬂux
pump of Mycobacterium tuberculo-
sis. J. Antimicrob. Chemother. 65,
1694–1701.

Smith, E. C., Kaatz, G. W., Seo, S.
M., Wareham, N., Williamson, E.
M., and Gibbons, S. (2007). The
phenolic diterpene totarol inhibits
multidrug efﬂux pump activity in
Staphylococcus aureus. Antimicrob.
Agents Chemother. 51, 4480–4483.

Solary, E., Mannone, L., Moreau, D.,
Caillot, D., Casasnovas, R. O., Guy,
H., Grandjean, M., Wolf,
J. E.,
Andre, F., and Fenaux, P. (2000).
Phase I study of cinchonine, a mul-
tidrug resistance reversing agent,
combined with the CHVP regimen
in relapsed and refractory lympho-
proliferative syndromes. Leukemia
14, 2085–2094.

Steffens, J. J., Pell, E. J., and Tien,
M. (1996). Mechanisms of fungicide
resistance in phytopathogenic fungi.
Curr. Opin. Biotechnol. 7, 348–355.

Steinbach, D., Sell, W., Voigt, A., Her-
mann, J., Zintl, F., and Sauerbrey,
A. (2002). BCRP gene expression
is associated with a poor response
to remission induction therapy in
childhood acute myeloid leukemia.
Leukemia 16, 1443–1447.

Stermitz, F. R., Beeson, T. D., Mueller, P.
J., Hsiang, J., and Lewis, K. (2001).
Staphylococcus aureus MDR efﬂux
pump inhibitors from a Berberis
and a Mahonia (sensu strictu)
species. Biochem. Syst. Ecol. 29,
793–798.

Stermitz, F. R., Lorenz, P., Tawara, J.
N., Zenewicz, L. A., and Lewis,
K. (2000a). Synergy in a med-
icinal plant, antimicrobial action
(cid:2)
-
of berberine potentiated by 5
methoxyhydnocarpin, a multidrug
pump inhibitor. Proc. Natl. Acad. Sci.
U.S.A. 97, 1433–1437.

Stermitz, F. R., Tawara-Matsuda,

(2000b), 5

J.,
Lorenz, P., Mueller, P., Zenewicz,
(cid:2)
L., and Lewis, K.
-
Methoxyhydnocarpin-D
and
pheophorbide A, Berberis species
components that potentiate berber-
ine growth inhibition of resistant
Staphylococcus aureus. J. Nat. Prod.
63, 1146–1149.

Stermitz, F. R., Scriven, L. N., Tegos, G.,
and Lewis, K. (2002). Two ﬂavonols
from Artemisia annua which poten-
tiate the activity of berberine and
norﬂoxacin against a resistant strain
of Staphylococcus aureus. Planta
Med. 68, 1140–1141.

Suttana, W., Mankhetkorn, S., Poompi-
mon, W., Palagani, A., Zhokhov, S.,
Gerlo, S., Haegeman, G., and Berghe,
W. V. (2010). Differential chemosen-
sitization of P-glycoprotein overex-
pressing K562/Adr cells by with-
aferin A and Siamois polyphenols.
Mol. Cancer 9, 99.

Suzuki, H., Tanabe, H., Mizukami, H.,
and Inoue, M. (2010). Selective
regulation of multidrug resistance
protein in vascular smooth mus-
cle cells by the isoquinoline alka-
loid coptisine. Biol. Pharm. Bull. 33,
677–682.

Tang, S., Bremner, P., Kortenkamp,
A., Schlage, C., Gray, A. I., Gib-
bons, S., and Heinrich, M. (2003).
Biﬂavonoids with cytotoxic and
antibacterial activity from Ochna
macrocalyx.
69,
247–253.

Planta Med.

Taur, J. S., and Rodriguez-Proteau, R.
(2008). Effects of dietary ﬂavonoids
on the transport of cimetidine via
P-glycoprotein and cationic trans-
porters in Caco-2 and LLC-PK1 cell
models. Xenobiotica 38, 1536–1550.
Tian, H., and Pan, O. C. (1997). Modula-
tion of multidrug resistance by three
bisbenzyl-isoquinolines in compari-
son with verapamil. Zhongguo Yao Li
Xue Bao 18, 455–458.

Tournier, N., Chevillard, L., Megarbane,
B., Pirnay, S., Scherrmann, J. M.,
and Decleves, X. (2010). Interac-
tion of drugs of abuse and main-
tenance treatments with human P-
glycoprotein (ABCB1) and breast
cancer resistance protein (ABCG2).
Int.
J. Neuropsychopharmacol. 13,
905–915.

Trompier, D., Baubichon-Cortay, H.,
Chang, X. B., Maitrejean, M., Barron,
D., Riordon, J. R., and Di Pietro, A.
(2003). Multiple ﬂavonoid-binding
sites within multidrug resistance
protein MRP1. Cell. Mol. Life Sci. 60,
2164–2177.

Twentyman,

P.
hen, N. M.
modiﬁcation

and

Blee-
R.,
(1991). Resistance
by
a

PSC-833,

Frontiers in Microbiology | Fungi and Their Interactions

April 2012 | Volume 3 | Article 130 | 14

Wink et al.

Inhibition of ABC transporter

novel
cyclosporin. Eur.
1639–1642.

non-immunosuppressive
J. Cancer 27,

van der Kolk, D. M., Vellenga, E., Müller,
M., and De Vries, E. G. E. (1999).
Multidrug resistance protein MRP1,
glutathione, and related enzymes –
their importance in acute myeloid
leukemia. Adv. Exp. Med. Biol. 457,
187–198.

van Gorkom, B. A., Timmer-Bosscha,
H., de Jong, S., van der Kolk, D.
M., Kleibeuker, J. H., and de Vries,
E. G. (2002). Cytotoxicity of rhein,
the active metabolite of sennoside
laxatives, is reduced by multidrug
resistance-associated protein 1. Br. J.
Cancer 86, 1494–1500.

Versantvoort, C. H., Broxterman, H. J.,
Lankelma, J., Feller, N., and Pinedo,
H. M. (1994). Competitive inhibi-
tion by genistein and ATP depen-
dence of daunorubicin transport in
intact MRP overexpressing human
small cell lung cancer cells. Biochem.
Pharmacol. 48, 1129–1136.

Versantvoort, C. H., Rhodes, T., and
Twentyman, P. R. (1996). Acceler-
ation of MRP-associated efﬂux of
rhodamine 123 by genistein and
related compounds. Br. J. Cancer 74,
1949–1954.

Wang, F. P., Wang, L., Yang, J. S.,
Nomura, M., and Miyamoto, K.
(2005). Reversal of P-glycoprotein-
dependent
resistance to vinblas-
tine by newly synthesized bisben-
zylisoquinoline alkaloids in mouse
leukemia P388 cells. Biol. Pharm.
Bull. 28, 1979–1982.

Wang, L., Bai, L., Nagasawa, T.,
Hasegawa, T., Yang, X., Sakai, J.,
Bai, Y., Kataoka, T., Oka, S., and
Hirose, K. (2008). Bioactive triter-
pene saponins from the roots of Phy-
tolacca americana. J. Nat. Prod. 71,
35–40.

Watanabe, T., Tsuge, H., Oh-Hara, T.,
Naito, M., and Tsuruo, T. (1995).
Comparative study on reversal efﬁ-
cacy of SDZ PSC 833, cyclosporin
A and verapamil on multidrug resis-
tance in vitro and in vivo. Acta Oncol
34, 235–241.

Weerasinghe, P., Hallock, S., Tang, S.
C., Trump, B., and Liepins, A.
(2006). Sanguinarine overcomes P-
glycoprotein-mediated multidrug-
resistance via induction of apop-
tosis and oncosis
in CEM-VLB
1000 cells. Exp. Toxicol. Pathol. 58,
21–30.

Wei, D., Mei, Y., and Liu, J. (2003).
Quantiﬁcation of doxorubicin and
validation of reversal effect of tea
polyphenols on multidrug resistance
in human carcinoma cells. Biotech-
nol. Lett. 25, 291–294.

Wesolowska, O., Hendrich, A. B.,
Laniapietrzak, B., Wisniewski,
J.,
Molnar, J., Ocsovszki, I., and Micha-
lak, K. (2009). Perturbation of the
lipid phase of a membrane is not
involved in the modulation of MRP1
transport activity by ﬂavonoids. Cell.
Mol. Biol. Lett. 14, 199–221.

Wesolowska, O., Wisniewski, J., Duarte,
N., Ferreira, M.
J., and Micha-
lak, K. (2007). Inhibition of MRP1
transport activity by phenolic and
terpenic compounds isolated from
Euphorbia species. Anticancer Res.
27, 4127–4133.

Wijnholds, J., deLange, E. C., Scheffer, G.
L., van den Berg, D. J., Mol, C. A., van
derValk, M., Schinkel,A. H., Scheper,
R. J., Breimer, D. D., and Borst, P.
(2000). Multidrug resistance protein
1 protects the choroid plexus epithe-
lium and contributes to the blood-
cerebrospinal ﬂuid barrier. J. Clin.
Invest. 105, 279–285.

Wink, M.

(1988). Plant breeding:
importance of plant
secondary
metabolites for protection against
pathogens and herbivores. Theor.
Appl. Genet. 75, 225–233.

Wink, M. (1993). Allelochemical prop-
erties and the raison d’être of
alkaloids. Alkaloids Chem. Biol. 43,
1–118.

Wink, M. (2000). Interference of alka-
loids with neuroreceptors and ion
channels. Nat. Prod. Res. 21, 3–129.
Wink, M. (2003). Evolution of sec-
ondary metabolites from an ecolog-
ical and molecular phylogenetic per-
spective. Phytochemistry 64, 3–19.

Wink, M. (2007). Molecular modes of
action of cytotoxic alkaloids- from
DNA intercalation, spindle poison-
ing,
topoisomerase inhibition to
apoptosis and multiple drug resis-
tance. Alkaloids Chem. Biol. 64, 1–48.
Wink, M. (2008a). Plant secondary
metabolism: diversity, function and
its evolution. Nat. Prod. Commun. 3,
1205–1216.

Wink, M. (2008b). Evolutionary advan-
tage
and molecular modes of
action of multi-component mix-
tures used in phytomedicine. Curr.
Drug Metab. 9, 996–1009.

Wink, M.

(2010a). Functions and
Biotechnology of Plant Secondary
Metabolites – Annual Plant Reviews,
Vol. 39. Chichester: Wiley-Blackwell.
Wink, M. (2010b). Biochemistry of Plant
Secondary Metabolism – Annual
Plant Reviews, Vol. 40. Chichester:
Wiley-Blackwell.

Wink, M., and Schimmer, O. (2010).
“Molecular modes of action of
defensive secondary metabolites,” in
Functions and Biotechnology of Plant
Secondary Metabolites,Vol. 39, ed. M.

Wink (Chichester: Wiley-Blackwell),
21–161.

Xu, W. L., Shen, H. L., Ao, Z. F., Chen, B.
A., Xia, W., Gao, F., and Zhang, Y. N.
(2006). Combination of tetrandrine
as a potential-reversing agent with
daunorubicin, etoposide and cytara-
bine for the treatment of refrac-
tory and relapsed acute myelogenous
leukemia. Leuk. Res. 30, 407–413.

Yasuda, K., Lan, L. B., Sanglard, D.,
Furuya, K., Schuetz,
J. D., and
Schuetz, E. G. (2002). Interaction of
cytochrome P450 3A inhibitors with
P-glycoprotein. J. Pharmacol. Exp.
Ther. 303, 323–332.

Ye, J., Zheng, Y., and Liu, D. (2009).
Reversal effect and its mechanism of
ampelopsin on multidrug resistance
in K562/ADR cells. Zhongguo Zhong
Yao Za Zhi 34, 761–765.

Yoo, H. H., Lee, M., Chung, H. J., Lee, S.
K., and Kim, D.-H. (2007). Effects
of diosmin, a ﬂavonoid glycoside
in citrus fruits, on P-glycoprotein-
mediated drug efﬂux in human
intestinal Caco-2 cells. J. Agric. Food
Chem. 55, 7620–7625.

of

Yoshida, N., Takagi, A., Kitazawa, H.,
Kawakami, J., and Adachi, I. (2005).
Inhibition
P-glycoprotein-
mediated transport by extracts of
and monoterpenoids contained in
Zanthoxyli
fructus. Toxicol. Appl.
Pharmacol. 209, 167–173.

You, G., and Morris, M. E. (2007). Drug
Transporters- Molecular Characteri-
zation and Role in Drug Disposition.
Hoboken, NJ: Wiley-Interscience.

You, M., Ma, X., Mukherjee, R.,
Farnsworth, N. R., Cordell, G.
A., Kinghorn, A. D., and Pez-
zuto, J. M. (1994). Indole alka-
loids
from Peschiera laeta that
enhance vinblastine-mediated cyto-
toxicity with multidrug-resistant
cells. J. Nat. Prod. 57, 1517–1522.

You, M., Wickramaratne, D. B., Silva,
G. L., Chai, H., Chagwedera, T. E.,
Farnsworth, N. R., Cordell, G. A.,
Kinghorn, A. D., and Pezzuto, J.
M. (1995). (-)-Roemerine, an apor-
phine alkaloid from Annona sene-
galensis that reverses the multidrug-
resistance phenotype with cultured
cells. J. Nat. Prod. 58, 598–604.

Zamora, J. M., Pearce, H. L., and Beck,
W. T.
(1988). Physical-chemical
properties shared by compounds
that modulate multidrug resistance
in human leukemic cells. Mol. Phar-
macol. 33, 454–462.

Zhang, S., and Morris, M. E. (2003).
Effects of the ﬂavonoids biochanin
A, morin, phloretin, and silymarin
on P-glycoprotein-mediated trans-
port. J. Pharmacol. Exp. Ther. 304,
1258–1267.

Zhang, S., Yang, X., and Morris, M.
E. (2004). Flavonoids are inhibitors
of breast cancer resistance protein
(ABCG2)-mediated transport. Mol.
Pharmacol. 65, 1208–1216.

Zhao, M., Bai, L., Wang, L., Toki,
A., Hasegawa, T., Kikuchi, M., Abe,
M., Sakai, J., Hasegawa, R., and
Bai, Y. (2007). Bioactive cardeno-
lides from the stems and twigs of
Nerium oleander. J. Nat. Prod. 70,
1098–1103.

Zhou, D. C., Zittoun, R., and Marie,
J. P. (1995). Homoharringtonine, an
effective new natural product in can-
cer chemotherapy. Bull. Cancer 82,
987–995.

Zhou, S., Lim, L. Y., and Chowbay, B.
(2004). Herbal modulation of P-
glycoprotein. Drug Metab. Rev. 36,
57–104.

Zhu, A., Wang, X., and Guo, Z. (2001).
Study of tea polyphenol as a rever-
sal agent for carcinoma cell lines’
multidrug resistance (study of TP as
a MDR reversal agent). Nucl. Med.
Biol. 28, 735–740.

Zhu, X., Sui, M., and Fan, W. (2005).
In vitro and in vivo characteriza-
tions of tetrandrine on the rever-
sal of P-glycoprotein-mediated drug
resistance to paclitaxel. Anticancer
Res. 25, 1953–1962.

Zupko,

I.,

J., Ocsovszki,

I., Rethy, B., Hohmann,

J.,
Molnar,
and
Falkay, G. (2009). Antitumor activ-
ity of
alkaloids derived from
Amaryllidaceae species. In vivo 23,
41–48.

Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.

Received: 12 January 2012; accepted: 19
March 2012; published online: 23 April
2012.
Citation: Wink M, Ashour ML and El-
Readi MZ (2012) Secondary metabolites
from plants inhibiting ABC transporters
and reversing resistance of cancer cells
and microbes to cytotoxic and antimicro-
bial agents. Front. Microbio. 3:130. doi:
10.3389/fmicb.2012.00130
This article was submitted to Frontiers in
Fungi and Their Interactions, a specialty
of Frontiers in Microbiology.
Copyright  2012 Wink, Ashour and
El-Readi. This is an open-access article
distributed under the terms of the Cre-
ative Commons Attribution Non Com-
mercial License, which permits non-
commercial use, distribution, and repro-
duction in other forums, provided the
original authors and source are credited.

www.frontiersin.org

April 2012 | Volume 3 | Article 130 | 15

